10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2013

Or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number 1-11239

HCA Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware	27-3865930
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
One Park Plaza Nashville, Tennessee	37203
(Address of principal executive offices)	(Zip Code)

(615) 344-9551

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨ (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

Class of Common Stock	Outstanding at April 30, 2013
Voting common stock, $.01 par value	446,077,900 shares

HCA HOLDINGS, INC.

Form 10-Q

March 31, 2013

		Page of Form 10-Q
Part I.	Financial Information
Item 1.	Financial Statements (Unaudited):
	Condensed Consolidated Income Statements — for the quarters ended March 31, 2013 and 2012	2
	Condensed Consolidated Comprehensive Income Statements — for the quarters ended March 31, 2013 and 2012	3
	Condensed Consolidated Balance Sheets — March 31, 2013 and December 31, 2012	4
	Condensed Consolidated Statements of Cash Flows  — for the quarters ended March 31, 2013 and 2012	5
	Notes to Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	42
Item 4.	Controls and Procedures	42
Part II.	Other Information
Item 1.	Legal Proceedings	42
Item 1A.	Risk Factors	44
Item 6.	Exhibits	45
Signatures		46

1

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED INCOME STATEMENTS

FOR THE QUARTERS ENDED MARCH 31, 2013 AND 2012

Unaudited

(Dollars in millions, except per share amounts)

	2013			2012
Revenues before provision for doubtful accounts	$	9,194		$	9,199
Provision for doubtful accounts		754			794
Revenues		8,440			8,405
Salaries and benefits		3,917			3,736
Supplies		1,479			1,419
Other operating expenses		1,523			1,493
Electronic health record incentive income		(39	)		(55	)
Equity in earnings of affiliates		(8	)		(11	)
Depreciation and amortization		424			417
Interest expense		472			442
Losses on sales of facilities		16			1
Loss on retirement of debt		17			—
		7,801			7,442
Income before income taxes		639			963
Provision for income taxes		201			324
Net income		438			639
Net income attributable to noncontrolling interests		94			99
Net income attributable to HCA Holdings, Inc.	$	344		$	540
Per share data:
Basic earnings per share	$	0.77		$	1.23
Diluted earnings per share	$	0.74		$	1.18
Cash dividends declared per share	$	—		$	2.00
Shares used in earnings per share calculations (in thousands):
Basic		444,401			437,936
Diluted		462,368			458,312

See accompanying notes.

2

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS

FOR THE QUARTERS ENDED MARCH 31, 2013 AND 2012

Unaudited

(Dollars in millions)

	2013			2012
Net income	$	438		$	639
Other comprehensive income (loss) before taxes:
Foreign currency translation		(60	)		29
Unrealized gains on available-for-sale securities		1			5
Defined benefit plans		—			—
Less: pension costs included in salaries and benefits		7			7
		7			7
Change in fair value of derivative financial instruments		(7	)		(25	)
Less: interest costs included in interest expense		32			29
		25			4
Other comprehensive income (loss) before taxes		(27	)		45
Income taxes (benefits) related to other comprehensive income items		(9	)		16
Other comprehensive income (loss)		(18	)		29
Comprehensive income		420			668
Comprehensive income attributable to noncontrolling interests		94			99
Comprehensive income attributable to HCA Holdings, Inc.	$	326		$	569

See accompanying notes.

3

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

Unaudited

(Dollars in millions)

	March 31, 2013			December 31, 2012
ASSETS
Current assets:
Cash and cash equivalents	$	594		$	705
Accounts receivable, less allowance for doubtful accounts of $4,796 and $4,846		4,877			4,672
Inventories		1,104			1,086
Deferred income taxes		385			385
Other		827			915
		7,787			7,763
Property and equipment, at cost		29,764			29,527
Accumulated depreciation		(16,620	)		(16,342	)
		13,144			13,185
Investments of insurance subsidiaries		423			515
Investments in and advances to affiliates		107			104
Goodwill and other intangible assets		5,541			5,539
Deferred loan costs		274			290
Other		606			679
	$	27,882		$	28,075
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	1,691		$	1,768
Accrued salaries		969			1,120
Other accrued expenses		1,893			1,849
Long-term debt due within one year		1,438			1,435
		5,991			6,172
Long-term debt		27,170			27,495
Professional liability risks		970			973
Income taxes and other liabilities		1,763			1,776
Stockholders’ deficit:
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 445,856,200 shares in 2013 and 443,200,200 shares in 2012		4			4
Capital in excess of par value		1,764			1,753
Accumulated other comprehensive loss		(475	)		(457	)
Retained deficit		(10,616	)		(10,960	)
Stockholders’ deficit attributable to HCA Holdings, Inc.		(9,323	)		(9,660	)
Noncontrolling interests		1,311			1,319
		(8,012	)		(8,341	)
	$	27,882		$	28,075

See accompanying notes.

4

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE QUARTERS ENDED MARCH 31, 2013 AND 2012

Unaudited

(Dollars in millions)

	2013			2012
Cash flows from operating activities:
Net income	$	438		$	639
Adjustments to reconcile net income to net cash provided by operating activities:
Changes in operating assets and liabilities		(1,294	)		(1,384	)
Provision for doubtful accounts		754			794
Depreciation and amortization		424			417
Income taxes		350			300
Losses on sales of facilities		16			1
Loss on retirement of debt		17			—
Amortization of deferred loan costs		13			14
Share-based compensation		23			9
Other		(1	)		7
Net cash provided by operating activities		740			797
Cash flows from investing activities:
Purchase of property and equipment		(404	)		(335	)
Acquisition of hospitals and health care entities		(22	)		(112	)
Disposition of hospitals and health care entities		1			1
Change in investments		51			6
Other		1			3
Net cash used in investing activities		(373	)		(437	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350
Net change in revolving credit facilities		390			(470	)
Repayment of long-term debt		(741	)		(93	)
Distributions to noncontrolling interests		(102	)		(93	)
Payment of debt issuance costs		—			(16	)
Distributions to stockholders		(10	)		(982	)
Income tax benefits		36			49
Other		(51	)		(7	)
Net cash used in financing activities		(478	)		(262	)
Change in cash and cash equivalents		(111	)		98
Cash and cash equivalents at beginning of period		705			373
Cash and cash equivalents at end of period	$	594		$	471
Interest payments	$	533		$	517
Income tax refunds, net	$	(185	)	$	(25	)

See accompanying notes.

5

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Reporting Entity

On November 17, 2006, HCA Inc. was acquired by a private investor group, including affiliates of or funds sponsored by Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co., BAML Capital Partners and HCA founder, Dr. Thomas F. Frist Jr. (collectively, the “Investors”) and by members of management and certain other investors. The transaction was accounted for as a recapitalization in our financial statements, with no adjustments to the historical basis of our assets and liabilities.

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure (the “Corporate Reorganization”). HCA Holdings, Inc. became the new parent company, and HCA Inc. became HCA Holdings, Inc.’s wholly-owned direct subsidiary. As part of the Corporate Reorganization, HCA Inc.’s outstanding shares of common stock were automatically converted, on a share for share basis, into identical shares of HCA Holdings, Inc.’s common stock. As a result of the Corporate Reorganization, HCA Holdings, Inc. was deemed the successor registrant to HCA Inc. under the Securities Exchange Act of 1934.

During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock. Upon the completion of a secondary offering in February 2013, we no longer qualify as a “controlled company” under the applicable New York Stock Exchange (“NYSE”) listing standards and will be required to appoint a board of directors comprised of a majority of independent members within one year of such date. Our common stock is traded on the NYSE (symbol “HCA”).

HCA Holdings, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At March 31, 2013, these affiliates owned and operated 162 hospitals, 113 freestanding surgery centers and provided extensive outpatient and ancillary services. HCA Holdings, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Inc. and its affiliates prior to the Corporate Reorganization and to HCA Holdings, Inc. and its affiliates after the Corporate Reorganization. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $66 million and $53 million for the quarters ended March 31, 2013 and 2012, respectively. Operating results for the quarter ended March 31, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2012.

Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies

6

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

Basis of Presentation (continued)

(under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters ended March 31, 2013 and 2012 are summarized in the following table (dollars in millions):

	2013			Ratio			2012			Ratio
Medicare	$	2,138			25.3	%	$	2,313			27.5	%
Managed Medicare		843			10.0			750			8.9
Medicaid		332			3.9			430			5.1
Managed Medicaid		401			4.8			342			4.1
Managed care and other insurers		4,486			53.2			4,445			52.9
International (managed care and other insurers)		290			3.4			260			3.1
		8,490			100.6			8,540			101.6
Uninsured		399			4.7			442			5.3
Other		305			3.6			217			2.6
Revenues before provision for doubtful accounts		9,194			108.9			9,199			109.5
Provision for doubtful accounts		(754	)		(8.9	)		(794	)		(9.5	)
Revenues	$	8,440			100.0	%	$	8,405			100.0	%

The growth rate in revenues for the quarter ended March 31, 2013 compared to the quarter ended March 31, 2012 was reduced due to Medicare revenues for the quarter ended March 31, 2012 being impacted by two adjustments: the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million. The net effect of these Medicare adjustments was an increase to revenues of $188 million. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the quarter ended March 31, 2012.

Certain prior year amounts have been reclassified to conform to the current year presentation.

NOTE 2 — ACQUISITIONS AND DISPOSITIONS

During the quarters ended March 31, 2013 and 2012, we paid $22 million and $54 million, respectively, to acquire nonhospital health care entities. During the quarter ended March 31, 2012, we paid $58 million, assumed liabilities of $34 million and recorded goodwill of $66 million related to the acquisition of a hospital facility in the American Group. During the quarter ended March 31, 2012, we recorded final adjustments to the purchase price allocation related to our 2011 acquisition of our partner’s interest in the HCA-HealthONE LLC joint venture. These adjustments resulted in a $30 million increase to noncontrolling interests, a $26 million reduction to property and equipment and a $56 million increase to goodwill.

During the quarter ended March 31, 2013, we recognized net pretax losses of $16 million related to the sale of a hospital facility and other real estate investments. During the quarter ended March 31, 2012, we recognized a net pretax loss of $1 million related to sales of real estate investments.

7

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 3 — INCOME TAXES

During the quarter ended March 31, 2013, we finalized settlements with the IRS resolving all outstanding issues for HCA Inc.’s 2007, 2008 and 2009 tax years. We expect the IRS Examination Division will begin an audit of HCA Holdings, Inc.’s 2010 and 2011 federal income tax returns in 2013.

Our liability for unrecognized tax benefits was $416 million, including accrued interest of $14 million, as of March 31, 2013 ($426 million and $14 million, respectively, as of December 31, 2012). Unrecognized tax benefits of $127 million ($125 million as of December 31, 2012) would affect the effective rate, if recognized. The provision for income taxes reflects $18 million and $3 million ($11 million and $2 million, respectively, net of tax) of reductions in interest expense related to taxing authority examinations for the quarters ended March 31, 2013 and 2012, respectively.

Depending on the completion of examinations by federal, state or international taxing authorities, the resolution of any tax disputes, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible our liability for unrecognized tax benefits may significantly increase or decline within the next 12 months. However, we are currently unable to estimate the range of any possible change.

NOTE 4 — EARNINGS PER SHARE

We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding, plus the dilutive effect of outstanding stock options, stock appreciation rights and restricted share units, computed using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share for the quarters ended March 31, 2013 and 2012 (dollars in millions, except per share amounts, and shares in thousands):

	2013		2012
Net income attributable to HCA Holdings, Inc.	$	344	$	540
Weighted average common shares outstanding		444,401		437,936
Effect of dilutive incremental shares		17,967		20,376
Shares used for diluted earnings per share		462,368		458,312
Earnings per share:
Basic earnings per share	$	0.77	$	1.23
Diluted earnings per share	$	0.74	$	1.18

8

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES

A summary of our insurance subsidiaries’ investments at March 31, 2013 and December 31, 2012 follows (dollars in millions):

	March 31, 2013
	Amortized Cost		Unrealized Amounts				Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	391	$	22	$	(1)	$	412
Auction rate securities		74		—		(4)		70
Asset-backed securities		12		—		—		12
Money market funds		51		—		—		51
		528		22		(5)		545
Equity securities		2		1		—		3
	$	530	$	23	$	(5)		548
Amounts classified as current assets								(125	)
Investment carrying value							$	423

	December 31, 2012
	Amortized Cost		Unrealized Amounts				Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	395	$	23	$	—	$	418
Auction rate securities		74		—		(6)		68
Asset-backed securities		14		—		—		14
Money market funds		67		—		—		67
		550		23		(6)		567
Equity securities		2		1		—		3
	$	552	$	24	$	(6)		570
Amounts classified as current assets								(55	)
Investment carrying value							$	515

At March 31, 2013 and December 31, 2012, the investments of our insurance subsidiaries were classified as “available-for-sale.” Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income. At both March 31, 2013 and December 31, 2012, $9 million of our investments were subject to restrictions included in insurance bond collateralization and assumed reinsurance contracts. Amounts classified as current assets at March 31, 2013 include a $59 million distribution receivable by the Company from an insurance subsidiary.

9

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES (continued)

Scheduled maturities of investments in debt securities at March 31, 2013 were as follows (dollars in millions):

	Amortized Cost		Fair Value
Due in one year or less	$	56	$	56
Due after one year through five years		180		188
Due after five years through ten years		113		120
Due after ten years		93		99
		442		463
Auction rate securities		74		70
Asset-backed securities		12		12
	$	528	$	545

The average expected maturity of the investments in debt securities at March 31, 2013 was 4.5 years, compared to the average scheduled maturity of 8.4 years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to the scheduled maturity date. The average expected maturities for our auction rate and asset-backed securities were derived from valuation models of expected cash flows and involved management’s judgment. At March 31, 2013, the average expected maturities for our auction rate and asset-backed securities were 5.8 years and 3.7 years, respectively, compared to average scheduled maturities of 23.9 years and 23.7 years, respectively.

NOTE 6 — FINANCIAL INSTRUMENTS

Interest Rate Swap Agreements

We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at March 31, 2013 (dollars in millions):

	Notional Amount		Maturity Date		Fair Value
Pay-fixed interest rate swaps	$	500		December 2014	$	(8	)
Pay-fixed interest rate swaps		3,000		December 2016		(326	)
Pay-fixed interest rate swaps		1,000		December 2017		(69	)

During the next 12 months, we estimate $125 million will be reclassified from other comprehensive income (“OCI”) to interest expense.

10

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 6 — FINANCIAL INSTRUMENTS (continued)

Cross Currency Swaps

The Company and certain subsidiaries have incurred obligations and entered into various intercompany transactions where such obligations are denominated in currencies, other than the functional currencies of the parties executing the trade. In order to mitigate the currency exposure risks and better match the cash flows of our obligations and intercompany transactions with cash flows from operations, we enter into cross currency swaps. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

Our cross currency swap is not designated as a hedge, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement at March 31, 2013 (amounts in millions):

	Notional Amount		Maturity Date		Fair Value
Euro — United States dollar currency swap		241 Euro		November 2013	$	(22	)

Derivatives — Results of Operations

The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the quarter ended March 31, 2013 (dollars in millions):

Derivatives in Cash Flow Hedging Relationships	Amount of Loss Recognized in OCI on Derivatives, Net of  Tax		Location of Loss Reclassified from Accumulated OCI into Operations		Amount of Loss Reclassified from Accumulated OCI into Operations
Interest rate swaps	$	4		Interest expense	$	32

Derivatives Not Designated as Hedging Instruments	Location of Loss Recognized in Operations on Derivatives		Amount of Loss Recognized in Operations on Derivatives
Cross currency swap		Other operating expenses	$	9

Credit-risk-related Contingent Features

We have agreements with each of our derivative counterparties that contain a provision where we could be declared in default on our derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to our default on the indebtedness. As of March 31, 2013, we have not been required to post any collateral related to these agreements. If we had breached these provisions at March 31, 2013, we would have been required to settle our obligations under the agreements at their aggregate, estimated termination value of $452 million.

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.

11

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

ASC 820 emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Cash Traded Investments

Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The transaction price is initially used as the best estimate of fair value.

Our wholly-owned insurance subsidiaries had investments in tax-exempt auction rate securities (“ARS”), which are backed by student loans substantially guaranteed by the federal government, of $70 million ($74 million par value) at March 31, 2013. We do not currently intend to attempt to sell the ARS as the liquidity needs of our insurance subsidiaries are expected to be met by other investments in their investment portfolios. During 2012, certain issuers and their broker/dealers redeemed or repurchased $65 million of our ARS at par value. There were no redemptions or repurchases during the quarter ended March 31, 2013. The valuation of these securities involved management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived a fair market value compared to tax-equivalent yields of other student loan backed variable rate securities of similar credit worthiness and similar effective maturities.

Derivative Financial Instruments

We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied

12

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

Derivative Financial Instruments (continued)

volatilities. We incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.

Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at March 31, 2013 and December 31, 2012, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of March 31, 2013 and December 31, 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	March 31, 2013
				Fair Value Measurements Using
	Fair Value			Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	412		$	—		$	412		$	—
Auction rate securities		70			—			—			70
Asset-backed securities		12			—			12			—
Money market funds		51			51			—			—
		545			51			424			70
Equity securities		3			2			—			1
Investments of insurance subsidiaries		548			53			424			71
Less amounts classified as current assets		(125	)		(51	)		(74	)		—
	$	423		$	2		$	350		$	71
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	22		$	—		$	22		$	—
Interest rate swaps (Income taxes and other liabilities)		403			—			403			—

13

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

Derivative Financial Instruments (continued)

	December 31, 2012
	Fair Value			Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	418		$	—		$	418	$	—
Auction rate securities		68			—			—		68
Asset-backed securities		14			—			14		—
Money market funds		67			67			—		—
		567			67			432		68
Equity securities		3			1			—		2
Investments of insurance subsidiaries		570			68			432		70
Less amounts classified as current assets		(55	)		(55	)		—		—
	$	515		$	13		$	432	$	70
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
Interest rate swaps (Income taxes and other liabilities)		429			—			429		—

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the quarter ended March 31, 2013 (dollars in millions):

Asset balances at December 31, 2012	$	70
Unrealized gains included in other comprehensive income		1
Asset balances at March 31, 2013	$	71

The estimated fair value of our long-term debt was $30.572 billion and $30.781 billion at March 31, 2013 and December 31, 2012, respectively, compared to carrying amounts aggregating $28.608 billion and $28.930 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

14

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 8 — LONG-TERM DEBT

A summary of long-term debt at March 31, 2013 and December 31, 2012, including related interest rates at March 31, 2013, follows (dollars in millions):

	March 31, 2013		December 31, 2012
Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	1,860	$	1,470
Senior secured revolving credit facility		—		—
Senior secured term loan facilities (effective interest rate of 5.6%)		5,941		5,958
Senior secured first lien notes (effective interest rate of 7.1%)		9,689		9,688
Other senior secured debt (effective interest rate of 7.0%)		424		423
First lien debt		17,914		17,539
Senior secured second lien notes		—		197
Senior unsecured notes (effective interest rate of 7.2%)		10,694		11,194
Total debt (average life of 6.9 years, rates averaging 6.5%)		28,608		28,930
Less amounts due within one year		1,438		1,435
	$	27,170	$	27,495

2013 Activity

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 7/8% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations or financial position.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

15

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS (continued)

Government Investigations, Claims and Litigation (continued)

As initially disclosed in 2010, the Civil Division of the Department of Justice (“DOJ”) has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other than peer reviews). The Company is cooperating with the government’s request and is currently producing medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.

Securities Class Action Litigation

On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court heard argument on the motion in April 2013. A decision on the motion is anticipated mid-to-late 2013.

In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named

16

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS (continued)

Securities Class Action Litigation (continued)

officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions have been consolidated in the Middle District of Tennessee and the parties have agreed that those cases shall be stayed pending developments in the shareholder class actions. The state derivative action has also been stayed pending developments in the shareholder class actions.

Health Midwest Litigation

In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. Should the accounting fail to satisfy the Court concerning HCA’s compliance with its capital and charity care commitments, the amount of the judgment award could substantially increase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are about $12 million. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling; however, the Company plans to appeal the ruling.

NOTE 10 — CAPITAL STRUCTURE

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):

	Equity (Deficit) Attributable to HCA Holdings, Inc.													Equity Attributable to Noncontrolling Interests			Total
	Common Stock				Capital in Excess  of Par Value			Accumulated Other Comprehensive Loss			Retained Deficit
	Shares (000)		ParValue
Balances at December 31, 2012		443,200	$	4	$	1,753		$	(457	)	$	(10,960	)	$	1,319		$	(8,341	)
Net income		—		—		—			—			344			94			438
Other comprehensive loss		—		—		—			(18	)		—			—			(18	)
Distributions		—		—		—			—			—			(102	)		(102	)
Share-based benefit plans		2,656		—		15			—			—			—			15
Other		—		—		(4	)		—			—			—			(4	)
Balances at March 31, 2013		445,856	$	4	$	1,764		$	(475	)	$	(10,616	)	$	1,311		$	(8,012	)

17

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 10 — CAPITAL STRUCTURE (continued)

The components of accumulated other comprehensive loss are as follows (dollars in millions):

	Unrealized Gains on Available- for-Sale Securities		Foreign Currency Translation Adjustments			Defined Benefit Plans			Change in Fair Value of Derivative Instruments			Total
Balances at December 31, 2012	$	11	$	(1	)	$	(196	)	$	(271	)	$	(457	)
Unrealized gains on available-for-sale securities, net of income taxes		1		—			—			—			1
Foreign currency translation adjustments, net of $21 income tax benefit		—		(39	)		—			—			(39	)
Defined benefit plans		—		—			—			—			—
Change in fair value of derivative instruments, net of $3 income tax benefit		—		—			—			(4	)		(4	)
Expense reclassified into operations from other comprehensive income, net of $3 and $12, respectively, income tax benefits		—		—			4			20			24
Balances at March 31, 2013	$	12	$	(40	)	$	(192	)	$	(255	)	$	(475	)

NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION

We operate in one line of business, which is operating hospitals and related health care entities. Effective January 1, 2013, we reorganized our operational groups into two geographically organized groups: the National and American Groups. The National Group includes 77 hospitals located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia, and the American Group includes 79 hospitals located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. We also operate six hospitals in England, and these facilities are included in the Corporate and other group.

18

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, losses on sales of facilities, loss on retirement of debt, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters ended March 31, 2013 and 2012 are summarized in the following table (dollars in millions):

	2013			2012
Revenues:
National Group	$	3,981		$	3,992
American Group		4,034			4,085
Corporate and other		425			328
	$	8,440		$	8,405
Equity in earnings of affiliates:
National Group	$	(2	)	$	(4	)
American Group		(6	)		(7	)
Corporate and other		—			—
	$	(8	)	$	(11	)
Adjusted segment EBITDA:
National Group	$	804		$	921
American Group		828			973
Corporate and other		(64	)		(71	)
	$	1,568		$	1,823
Depreciation and amortization:
National Group	$	174		$	173
American Group		202			203
Corporate and other		48			41
	$	424		$	417
Adjusted segment EBITDA	$	1,568		$	1,823
Depreciation and amortization		424			417
Interest expense		472			442
Losses on sales of facilities		16			1
Loss on retirement of debt		17			—
Income before income taxes	$	639		$	963

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure. HCA Holdings, Inc. became the parent company, and HCA Inc. became HCA Holdings, Inc.’s wholly-owned direct subsidiary. On November 23, 2010, HCA Holdings, Inc. issued $1.525 billion aggregate principal amount of 7 ³/₄% senior unsecured notes due 2021. On December 6, 2012, HCA Holdings, Inc. issued $1.000 billion aggregate principal amount of 6.25% senior unsecured notes due 2021. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries.

19

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, wholly-owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our senior secured asset-based revolving credit facility).

Our summarized condensed consolidating comprehensive income statements for the quarters ended March 31, 2013 and 2012, condensed consolidating balance sheets at March 31, 2013 and December 31, 2012 and condensed consolidating statements of cash flows for the quarter ended March 31, 2013 and 2012, segregating HCA Holdings, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow:

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED MARCH 31, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,872		$	4,322		$	—		$	9,194
Provision for doubtful accounts		—			—			443			311			—			754
Revenues		—			—			4,429			4,011			—			8,440
Salaries and benefits		—			—			2,127			1,790			—			3,917
Supplies		—			—			791			688			—			1,479
Other operating expenses		1			—			732			790			—			1,523
Electronic health record incentive income		—			—			(29	)		(10	)		—			(39	)
Equity in earnings of affiliates		(356	)		—			(1	)		(7	)		356			(8	)
Depreciation and amortization		—			—			209			215			—			424
Interest expense		46			558			(106	)		(26	)		—			472
Losses on sales of facilities		—			—			16			—			—			16
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(183	)		183			—			—
		(309	)		575			3,556			3,623			356			7,801
Income (loss) before income taxes		309			(575	)		873			388			(356	)		639
Provision (benefit) for income taxes		(17	)		(212	)		317			113			—			201
Net income (loss)		326			(363	)		556			275			(356	)		438
Net income attributable to noncontrolling interests		—			—			13			81			—			94
Net income (loss) attributable to HCA Holdings, Inc.	$	326		$	(363	)	$	543		$	194		$	(356	)	$	344
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	326		$	(347	)	$	547		$	156		$	(356	)	$	326

20

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED MARCH 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,903		$	4,296		$	—		$	9,199
Provision for doubtful accounts		—			—			463			331			—			794
Revenues		—			—			4,440			3,965			—			8,405
Salaries and benefits		—			—			1,982			1,754			—			3,736
Supplies		—			—			753			666			—			1,419
Other operating expenses		—			4			729			760			—			1,493
Electronic health record incentive income		—			—			(41	)		(14	)		—			(55	)
Equity in earnings of affiliates		(560	)		—			(2	)		(9	)		560			(11	)
Depreciation and amortization		—			—			200			217			—			417
Interest expense		30			529			(91	)		(26	)		—			442
Losses on sales of facilities		—			—			1			—			—			1
Management fees		—			—			(160	)		160			—			—
		(530	)		533			3,371			3,508			560			7,442
Income (loss) before income taxes		530			(533	)		1,069			457			(560	)		963
Provision (benefit) for income taxes		(10	)		(200	)		392			142			—			324
Net income (loss)		540			(333	)		677			315			(560	)		639
Net income attributable to noncontrolling interests		—			—			17			82			—			99
Net income (loss) attributable to HCA Holdings, Inc.	$	540		$	(333	)	$	660		$	233		$	(560	)	$	540
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	540		$	(329	)	$	664		$	254		$	(560	)	$	569

21

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

MARCH 31, 2013

(Dollars in millions)

	HCA Holdings,  Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	1		$	—		$	272		$	321	$	—		$	594
Accounts receivable, net		—			—			2,503			2,374		—			4,877
Inventories		—			—			647			457		—			1,104
Deferred income taxes		385			—			—			—		—			385
Other		—			—			317			510		—			827
		386			—			3,739			3,662		—			7,787
Property and equipment, net		—			—			7,444			5,700		—			13,144
Investments of insurance subsidiaries		—			—			—			423		—			423
Investments in and advances to affiliates		18,837			—			16			91		(18,837	)		107
Goodwill and other intangible assets		—			—			1,697			3,844		—			5,541
Deferred loan costs		32			242			—			—		—			274
Other		396			—			25			185		—			606
	$	19,651		$	242		$	12,921		$	13,905	$	(18,837	)	$	27,882
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	1		$	—		$	1,126		$	564	$	—		$	1,691
Accrued salaries		—			—			569			400		—			969
Other accrued expenses		247			454			400			792		—			1,893
Long-term debt due within one year		—			1,363			40			35		—			1,438
		248			1,817			2,135			1,791		—			5,991
Long-term debt		2,525			23,988			173			484		—			27,170
Intercompany balances		25,750			(11,633	)		(17,525	)		3,408		—			—
Professional liability risks		—			—			—			970		—			970
Income taxes and other liabilities		451			425			652			235		—			1,763
		28,974			14,597			(14,565	)		6,888		—			35,894
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,323	)		(14,355	)		27,394			5,798		(18,837	)		(9,323	)
Noncontrolling interests		—			—			92			1,219		—			1,311
		(9,323	)		(14,355	)		27,486			7,017		(18,837	)		(8,012	)
	$	19,651		$	242		$	12,921		$	13,905	$	(18,837	)	$	27,882

22

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	22		$	—		$	383		$	300	$	—		$	705
Accounts receivable, net		—			—			2,448			2,224		—			4,672
Inventories		—			—			629			457		—			1,086
Deferred income taxes		385			—			—			—		—			385
Other		122			—			342			451		—			915
		529			—			3,802			3,432		—			7,763
Property and equipment, net		—			—			7,417			5,768		—			13,185
Investments of insurance subsidiaries		—			—			—			515		—			515
Investments in and advances to affiliates		18,481			—			16			88		(18,481	)		104
Goodwill and other intangible assets		—			—			1,697			3,842		—			5,539
Deferred loan costs		32			258			—			—		—			290
Other		469			—			31			179		—			679
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,203		$	565	$	—		$	1,768
Accrued salaries		—			—			638			482		—			1,120
Other accrued expenses		30			567			464			788		—			1,849
Long-term debt due within one year		—			1,360			39			36		—			1,435
		30			1,927			2,344			1,871		—			6,172
Long-term debt		2,525			24,304			173			493		—			27,495
Intercompany balances		26,131			(12,407	)		(17,130	)		3,406		—			—
Professional liability risks		—			—			—			973		—			973
Income taxes and other liabilities		485			442			629			220		—			1,776
		29,171			14,266			(13,984	)		6,963		—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,660	)		(14,008	)		26,847			5,642		(18,481	)		(9,660	)
Noncontrolling interests		—			—			100			1,219		—			1,319
		(9,660	)		(14,008	)		26,947			6,861		(18,481	)		(8,341	)
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075

23

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE QUARTER ENDED MARCH 31, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	326		$	(363	)	$	556		$	275		$	(356	)	$	438
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		49			(113	)		(671	)		(559	)		—			(1,294	)
Provision for doubtful accounts		—			—			443			311			—			754
Depreciation and amortization		—			—			209			215			—			424
Income taxes		350			—			—			—			—			350
Losses on sales of facilities		—			—			16			—			—			16
Loss on retirement of debt		—			17			—			—			—			17
Amortization of deferred loan costs		1			12			—			—			—			13
Share-based compensation		23			—			—			—			—			23
Equity in earnings of affiliates		(356	)		—			—			—			356			—
Other		—			2			1			(4	)		—			(1	)
Net cash provided by (used in) operating activities		393			(445	)		554			238			—			740
Cash flows from investing activities:
Purchase of property and equipment		—			—			(241	)		(163	)		—			(404	)
Acquisition of hospitals and health care entities		—			—			—			(22	)		—			(22	)
Disposition of hospitals and health care entities		—			—			1			—			—			1
Change in investments		—			—			5			46			—			51
Other		—			—			—			1			—			1
Net cash used in investing activities		—			—			(235	)		(138	)		—			(373	)
Cash flows from financing activities:
Net change in revolving bank credit facilities		—			390			—			—			—			390
Repayment of long-term debt		—			(718	)		(11	)		(12	)		—			(741	)
Distributions to noncontrolling interests		—			—			(21	)		(81	)		—			(102	)
Distributions to stockholders		(10	)		—			—			—			—			(10	)
Changes in intercompany balances with affiliates, net		(393	)		773			(398	)		18			—			—
Income tax benefits		36			—			—			—			—			36
Other		(47	)		—			—			(4	)		—			(51	)
Net cash (used in) provided by financing activities		(414	)		445			(430	)		(79	)		—			(478	)
Change in cash and cash equivalents		(21	)		—			(111	)		21			—			(111	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	1		$	—		$	272		$	321		$	—		$	594

24

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE QUARTERS ENDED MARCH 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	540		$	(333	)	$	677		$	315		$	(560	)	$	639
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		30			(116	)		(819	)		(479	)		—			(1,384	)
Provision for doubtful accounts		—			—			463			331			—			794
Depreciation and amortization		—			—			200			217			—			417
Income taxes		300			—			—			—			—			300
Losses on sales of facilities		—			—			1			—			—			1
Amortization of deferred loan costs		—			14			—			—			—			14
Share-based compensation		9			—			—			—			—			9
Equity in earnings of affiliates		(560	)		—			—			—			560			—
Other		—			4			—			3			—			7
Net cash provided by (used in) operating activities		319			(431	)		522			387			—			797
Cash flows from investing activities:
Purchase of property and equipment		—			—			(162	)		(173	)		—			(335	)
Acquisition of hospitals and health care entities		—			—			(62	)		(50	)		—			(112	)
Disposition of hospitals and health care entities		—			—			1			—			—			1
Change in investments		—			—			2			4			—			6
Other		—			—			—			3			—			3
Net cash used in investing activities		—			—			(221	)		(216	)		—			(437	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350			—			—			—			1,350
Net change in revolving bank credit facilities		—			(470	)		—			—			—			(470	)
Repayment of long-term debt		—			(76	)		(14	)		(3	)		—			(93	)
Distributions to noncontrolling interests		—			—			(18	)		(75	)		—			(93	)
Payment of debt issuance costs		—			(16	)		—			—			—			(16	)
Distributions to stockholders		(982	)		—			—			—			—			(982	)
Changes in intercompany balances with affiliates, net		624			(357	)		(240	)		(27	)		—			—
Income tax benefits		49			—			—			—			—			49
Other		(10	)		—			—			3			—			(7	)
Net cash (used in) provided by financing activities		(319	)		431			(272	)		(102	)		—			(262	)
Change in cash and cash equivalents		—			—			29			69			—			98
Cash and cash equivalents at beginning of period		—			—			115			258			—			373
Cash and cash equivalents at end of period	$	—		$	—		$	144		$	327		$	—		$	471

25

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

This quarterly report on Form 10-Q includes certain disclosures which contain “forward-looking statements.” Forward-looking statements include statements regarding estimated electronic health record (“EHR”) incentive income and related EHR operating expenses, expected capital expenditures, expected net claim payments and all other statements that do not relate solely to historical or current facts, and can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, (2) the effects related to the enactment and implementation of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the “Health Reform Law”), the possible enactment of additional federal or state health care reforms and possible changes to the Health Reform Law and other federal, state or local laws or regulations affecting the health care industry, (3) the effects related to the enactment and implementation of the Budget Control Act of 2011 (the “BCA”) and the outcome of negotiations and legislation related to BCA-mandated spending reductions, which include cuts to Medicare payments, (4) increases in the amount and risk of collectibility of uninsured accounts and deductibles and copayment amounts for insured accounts, (5) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (6) possible changes in the Medicare, Medicaid and other state programs, including Medicaid upper payment limit (“UPL”) programs or Waiver Programs, that may impact reimbursements to health care providers and insurers, (7) the highly competitive nature of the health care business, (8) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under managed care agreements, the ability to enter into and renew managed care provider agreements on acceptable terms and the impact of consumer driven health plans and physician utilization trends and practices, (9) the efforts of insurers, health care providers and others to contain health care costs, (10) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (11) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (12) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (13) changes in accounting practices, (14) changes in general economic conditions nationally and regionally in our markets, (15) future divestitures which may result in charges and possible impairments of long-lived assets, (16) changes in business strategy or development plans, (17) delays in receiving payments for services provided, (18) the outcome of pending and any future tax audits, appeals and litigation associated with our tax positions, (19) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (20) our ongoing ability to demonstrate meaningful use of certified EHR technology and recognize income for the related Medicare or Medicaid incentive payments, and (21) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2012 and our other filings with the Securities and Exchange Commission. As a consequence, current plans, anticipated actions and future financial position and results of operations may differ from those expressed in any forward-looking statements made by or on behalf of HCA. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this report, which forward-looking statements reflect management’s views only as of the date of this report. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise.

Health Care Reform

As enacted, the Health Reform Law will change how health care services are covered, delivered and reimbursed through expanded coverage of uninsured individuals, reduced growth in Medicare program spending,

26

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Health Care Reform (continued)

reductions in Medicare and Medicaid Disproportionate Share Hospital (“DSH”) payments, and the establishment of programs in which reimbursement is tied to quality and integration. In addition, the Health Reform Law reforms certain aspects of health insurance, expands existing efforts to tie Medicare and Medicaid payments to performance and quality, and contains provisions intended to strengthen fraud and abuse enforcement. Numerous lawsuits have challenged the constitutionality of the Health Reform Law. On June 28, 2012, the United States Supreme Court upheld the constitutionality of the individual mandate provisions of the Health Reform Law but struck down the provisions that would have allowed the Department of Health and Human Services (“HHS”) to penalize states that do not implement the Medicaid expansion provisions with the loss of existing federal Medicaid funding. States that choose not to implement the Medicaid expansion will forego funding established by the Health Reform Law to cover most of the expansion costs. It is unclear how many states will decline to implement the Medicaid expansion. Due to these factors, we are unable to predict with any reasonable certainty or otherwise quantify the likely impact of the Health Reform Law on our business model, financial condition or result of operations.

First Quarter 2013 Operations Summary

Revenues increased to $8.440 billion in the first quarter of 2013 from $8.405 billion in the first quarter of 2012. Net income attributable to HCA Holdings, Inc. totaled $344 million, or $0.74 per diluted share, for the quarter ended March 31, 2013, compared to $540 million, or $1.18 per diluted share, for the quarter ended March 31, 2012. First quarter 2013 results include net losses on sales of facilities of $16 million, or $0.02 per diluted share, and a loss on retirement of debt of $17 million, or $0.03 per diluted share. First quarter 2012 results include two Medicare revenue adjustments (and related expenses) that added $170 million to income before income taxes, or $0.22 per diluted share. All “per diluted share” disclosures are based upon amounts net of the applicable income taxes. Shares used for diluted earnings per share were 462.4 million shares for the quarter ended March 31, 2013 and 458.3 million shares for the quarter ended March 31, 2012.

Revenues increased 0.4% on a consolidated basis and increased 0.1% on a same facility basis for the quarter ended March 31, 2013, compared to the quarter ended March 31, 2012. The increase in consolidated revenues can be attributed primarily to the net impact of a 0.9% increase in revenue per equivalent admission and a 0.4% decline in equivalent admissions. The same facility revenues increase resulted primarily from the net impact of a 0.8% increase in same facility revenue per equivalent admission and a 0.7% decline in same facility equivalent admissions.

During the quarter ended March 31, 2013, consolidated admissions and same facility admissions increased 0.2% and 0.1%, respectively, compared to the quarter ended March 31, 2012. Inpatient surgeries declined 2.8% on a consolidated basis and 2.6% on a same facility basis during the quarter ended March 31, 2013, compared to the quarter ended March 31, 2012. Outpatient surgeries declined 2.9% on a consolidated basis and 4.3% on a same facility basis during the quarter ended March 31, 2013, compared to the quarter ended March 31, 2012. Emergency department visits increased 3.6% on a consolidated basis and 3.8% on a same facility basis during the quarter ended March 31, 2013, compared to the quarter ended March 31, 2012. Quarterly patient volume statistic comparisons were negatively impacted due to the additional day (leap day) in the quarter ended March 31, 2012.

For the quarter ended March 31, 2013, the provision for doubtful accounts declined $40 million, compared to the quarter ended March 31, 2012. The self-pay revenue deductions for charity care and uninsured discounts increased $107 million and $311 million, respectively, during the first quarter of 2013, compared to the first quarter of 2012. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, provision for doubtful accounts, uninsured discounts and charity care, was

27

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

First Quarter 2013 Operations Summary (continued)

30.0% for the first quarter of 2013, compared to 27.8% for the first quarter of 2012. Same facility uninsured admissions increased 5.4% and same facility uninsured emergency room visits increased 3.5% for the quarter ended March 31, 2013, compared to the quarter ended March 31, 2012.

Interest expense increased $30 million to $472 million for the quarter ended March 31, 2013 from $442 million for the quarter ended March 31, 2012. The increase in interest expense was due to increases in both the average debt balance and average interest rate.

Cash flows from operating activities declined $57 million from $797 million for the first quarter of 2012 to $740 million for the first quarter of 2013. The decline is primarily related to the net impact of the decline in net income of $168 million, excluding the losses on sales of facilities of $16 million and loss on retirement of debt of $17 million, being partially offset by a positive impact from changes in working capital items of $50 million and a reduction of $50 million in income taxes.

Results of Operations

Revenue/Volume Trends

Our revenues depend upon inpatient occupancy levels, the ancillary services and therapy programs ordered by physicians and provided to patients, the volume of outpatient procedures and the charge and negotiated payment rates for such services. Gross charges typically do not reflect what our facilities are actually paid. Our facilities have entered into agreements with third-party payers, including government programs and managed care health plans, under which the facilities are paid based upon the cost of providing services, predetermined rates per diagnosis, fixed per diem rates or discounts from gross charges. We do not pursue collection of amounts related to patients who meet our guidelines to qualify for charity care; therefore, they are not reported in revenues. We provide discounts to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. After the discounts are applied, we are still unable to collect a significant portion of uninsured patients’ accounts, and we record significant provisions for doubtful accounts (based upon our historical collection experience) related to uninsured patients in the period the services are provided.

28

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

Revenues increased 0.4% from $8.405 billion in the first quarter of 2012 to $8.440 billion in the first quarter of 2013. Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from our third-party payers, the uninsured and other revenues for the quarters ended March 31, 2013 and 2012 are summarized in the following tables (dollars in millions):

	2013			Ratio			2012			Ratio
Medicare	$	2,138			25.3	%	$	2,313			27.5	%
Managed Medicare		843			10.0			750			8.9
Medicaid		332			3.9			430			5.1
Managed Medicaid		401			4.8			342			4.1
Managed care and other insurers		4,486			53.2			4,445			52.9
International (managed care and other insurers)		290			3.4			260			3.1
		8,490			100.6			8,540			101.6
Uninsured		399			4.7			442			5.3
Other		305			3.6			217			2.6
Revenues before provision for doubtful accounts		9,194			108.9			9,199			109.5
Provision for doubtful accounts		(754	)		(8.9	)		(794	)		(9.5	)
Revenues	$	8,440			100.0	%	$	8,405			100.0	%

The growth rate in revenues for the quarter ended March 31, 2013 compared to the quarter ended March 31, 2012 was reduced due to Medicare revenues for the quarter ended March 31, 2012 being impacted by two adjustments to Medicare revenues (the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million). The net effect of these Medicare adjustments was an increase of $188 million to revenues. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the quarter ended March 31, 2012.

Consolidated and same facility revenue per equivalent admission increased 0.9% and 0.8%, respectively, in the first quarter of 2013, compared to the first quarter of 2012. Consolidated and same facility equivalent admissions declined 0.4% and 0.7%, respectively, in the first quarter of 2013, compared to the first quarter of 2012. Consolidated and same facility admissions increased 0.2% and 0.1%, respectively, in the first quarter of 2013, compared to the first quarter of 2012. Consolidated and same facility outpatient surgeries declined 2.9% and 4.3%, respectively, in the first quarter of 2013, compared to the first quarter of 2012. Consolidated and same facility inpatient surgeries declined 2.8% and 2.6%, respectively, in the first quarter of 2013, compared to the first quarter of 2012. Consolidated and same facility emergency department visits increased 3.6% and 3.8%, respectively, in the first quarter of 2013, compared to the first quarter of 2012.

To quantify the total impact of and trends related to uninsured accounts, we believe it is beneficial to view the direct uninsured revenue deductions and provision for doubtful accounts in combination, rather than each separately. At March 31, 2013, our allowance for doubtful accounts represented approximately 93% of the

29

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

$5.179 billion total patient due accounts receivable balance. The patient due accounts receivable balance represents the estimated uninsured portion of our accounts receivable. A summary of these adjustments to revenues amounts, related to uninsured accounts, for the quarters ended March 31, 2013 and 2012 follows (dollars in millions):

	2013		Ratio			2012		Ratio
Charity care	$	905		25	%	$	798		25	%
Uninsured discounts		1,950		54			1,639		51
Provision for doubtful accounts		754		21			794		24
Totals	$	3,609		100	%	$	3,231		100	%

Same facility uninsured admissions increased by 1,688 admissions, or 5.4%, in the first quarter of 2013, compared to the first quarter of 2012. Same facility uninsured admissions in 2012, compared to 2011, increased 11.0% in the fourth quarter of 2012, increased 7.3% in the third quarter of 2012, increased 8.9% in the second quarter of 2012 and increased 11.6% in the first quarter of 2012.

The approximate percentages of our admissions related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and other insurers and the uninsured for the quarters ended March 31, 2013 and 2012 are set forth in the following table.

	2013			2012
Medicare		33	%		34	%
Managed Medicare		14			12
Medicaid		8			9
Managed Medicaid		9			8
Managed care and other insurers		29			30
Uninsured		7			7
		100	%		100	%

The approximate percentages of our inpatient revenues, before provision for doubtful accounts, related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and other insurers and the uninsured for the quarters ended March 31, 2013 and 2012 are set forth in the following table.

	2013			2012
Medicare		32	%		34	%
Managed Medicare		11			10
Medicaid		5			6
Managed Medicaid		5			4
Managed care and other insurers		46			44
Uninsured		1			2
		100	%		100	%

At March 31, 2013, we had 74 hospitals in the states of Texas and Florida. During the first quarter of 2013, 55% of our admissions and 46% of our revenues were generated by these hospitals. Uninsured admissions in Texas and Florida represented 61% of our uninsured admissions during the first quarter of 2013.

30

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

We receive a significant portion of our revenues from government health programs, principally Medicare and Medicaid, which are highly regulated and subject to frequent and substantial changes. We provide indigent care services in several communities in the state of Texas, in affiliation with other hospitals. The state of Texas has been involved in efforts to increase the indigent care provided by private hospitals. As a result of additional indigent care being provided by private hospitals, public hospital districts or counties in Texas have available funds that were previously devoted to indigent care. The public hospital districts or counties are under no contractual or legal obligation to provide such indigent care. The public hospital districts or counties have elected to transfer some portion of these available funds to the state’s Medicaid program. Such action is at the sole discretion of the public hospital districts or counties. It is anticipated that these contributions to the state will be matched with federal Medicaid funds. The state then may make supplemental payments to hospitals in the state for Medicaid services rendered. Hospitals receiving Medicaid supplemental payments may include those that are providing additional indigent care services. Our Texas Medicaid revenues included $79 million and $128 million during the first quarters of 2013 and 2012, respectively, of Medicaid supplemental payments. In addition, we receive supplemental payments in several other states. We are aware these supplemental payment programs are currently being reviewed by certain state agencies and some states have made waiver requests to the Centers for Medicare and Medicaid Services (“CMS”) to replace their existing supplemental payment programs. It is possible these reviews and waiver requests will result in the restructuring of such supplemental payment programs and could result in the payment programs being reduced or eliminated. In 2011, CMS approved a Medicaid waiver that allows Texas to continue receiving supplemental Medicaid reimbursement while expanding its Medicaid managed care program, thus Texas is operating pursuant to a Waiver Program. However, we cannot predict whether the Texas private supplemental Medicaid reimbursement program will continue or guarantee that revenues recognized for the program will not decline. Because deliberations about these programs are ongoing, we are unable to estimate the financial impact the program structure modifications, if any, may have on our results of operations.

Electronic Health Record Incentive Payments

The American Recovery and Reinvestment Act of 2009 provides for Medicare and Medicaid incentive payments for eligible hospitals and professionals that adopt and meaningfully use certified EHR technology. We recognize income related to Medicare and Medicaid incentive payments using a gain contingency model that is based upon when our eligible hospitals have demonstrated meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.

We recognized $39 million and $55 million of electronic health record incentive income, primarily related to Medicare, during the first quarters of 2013 and 2012, respectively. At March 31, 2013, we have $80 million of deferred EHR incentive income, which represents incentive payments received for which EHR incentive income has not been recognized.

We have incurred and will continue to incur both capital costs and operating expenses in order to implement our certified EHR technology and meet meaningful use requirements. These expenses are ongoing and are projected to continue over all stages of implementation of meaningful use. The timing of recognizing the expenses may not correlate with the receipt of the incentive payments and the recognition of revenues. For the first quarters of 2013 and 2012, respectively, we incurred $26 million and $17 million of operating expenses to implement our certified EHR technology and meet meaningful use.

31

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Electronic Health Record Incentive Payments (continued)

For 2013, we estimate EHR incentive income will be recognized in the range of $200 million to $225 million and that related EHR operating expenses will be in the range of $130 million to $150 million. Actual incentive payments and EHR operating expenses could vary from these estimates due to certain factors such as availability of federal funding for both Medicare and Medicaid incentive payments and our ability to continue to demonstrate meaningful use of certified EHR technology. The failure of our ability to continue to demonstrate meaningful use of EHR technology could have a material, adverse effect on our results of operations.

32

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Operating Results Summary

The following is a comparative summary of results from operations for the quarters ended March 31, 2013 and 2012 (dollars in millions):

	2013						2012
	Amount			Ratio			Amount			Ratio
Revenues before provision for doubtful accounts	$	9,194					$	9,199
Provision for doubtful accounts		754						794
Revenues		8,440			100.0			8,405			100.0
Salaries and benefits		3,917			46.4			3,736			44.5
Supplies		1,479			17.5			1,419			16.9
Other operating expenses		1,523			18.1			1,493			17.6
Electronic health record incentive income		(39	)		(0.5	)		(55	)		(0.6	)
Equity in earnings of affiliates		(8	)		(0.1	)		(11	)		(0.1	)
Depreciation and amortization		424			5.0			417			4.9
Interest expense		472			5.6			442			5.3
Losses on sales of facilities		16			0.2			1			—
Loss on retirement of debt		17			0.2			—			—
		7,801			92.4			7,442			88.5
Income before income taxes		639			7.6			963			11.5
Provision for income taxes		201			2.4			324			3.9
Net income		438			5.2			639			7.6
Net income attributable to noncontrolling interests		94			1.1			99			1.2
Net income attributable to HCA Holdings, Inc.	$	344			4.1		$	540			6.4
% changes from prior year:
Revenues		0.4	%					13.5	%
Income before income taxes		(33.6	)					86.4
Net income attributable to HCA Holdings, Inc.		(36.3	)					125.2
Admissions(a)		0.2						9.0
Equivalent admissions(b)		(0.4	)					11.4
Revenue per equivalent admission		0.9						1.9
Same facility % changes from prior year(c):
Revenues		0.1						5.1
Admissions(a)		0.1						3.2
Equivalent admissions(b)		(0.7	)					4.8
Revenue per equivalent admission		0.8						0.3

(a) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(b) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenues and gross outpatient revenues and then dividing the resulting amount by gross inpatient revenues. The equivalent admissions computation “equates” outpatient revenues to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.

(c) Same facility information excludes the operations of hospitals and their related facilities which were either acquired or divested during the current and prior period.

33

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Quarters Ended March 31, 2013 and 2012

Net income attributable to HCA Holdings, Inc. totaled $344 million, or $0.74 per diluted share, for the first quarter of 2013 compared to $540 million, or $1.18 per diluted share, for the first quarter of 2012. First quarter 2013 results include net losses on sales of facilities of $16 million, or $0.02 per diluted share, and a loss on retirement of debt of $17 million, or $0.03 per diluted share. First quarter 2012 results include two Medicare adjustments (and related expenses) that added $170 million to income before income taxes, or $0.22 per diluted share. All “per diluted share” disclosures are based upon amounts net of the applicable income taxes. Shares used for diluted earnings per share were 462.4 million shares and 458.3 million shares for the quarters ended March 31, 2013 and 2012, respectively.

For the first quarter of 2013, consolidated and same facility admissions increased 0.2% and 0.1%, respectively, compared to the first quarter of 2012. Consolidated and same facility outpatient surgical volumes declined 2.9% and 4.3%, respectively, during the first quarter of 2013, compared to the first quarter of 2012. Consolidated and same facility inpatient surgeries declined 2.8% and 2.6%, respectively, in the first quarter of 2013, compared to the first quarter of 2012. Consolidated and same facility emergency department visits increased 3.6% and 3.8%, respectively, during the quarter ended March 31, 2013, compared to the quarter ended March 31, 2012.

Revenues before provision for doubtful accounts declined 0.1% for the first quarter of 2013 compared to the first quarter of 2012. Provision for doubtful accounts declined $40 million from $794 million in the first quarter of 2012 to $754 million in the first quarter of 2013. The provision for doubtful accounts relates primarily to uninsured amounts due directly from patients, including copayment and deductible amounts for patients who have health care coverage. The self-pay revenue deductions for charity care and uninsured discounts increased $107 million and $311 million, respectively, during the first quarter of 2013, compared to the first quarter of 2012. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, the provision for doubtful accounts, uninsured discounts and charity care, was 30.0% for the first quarter of 2013, compared to 27.8% for the first quarter of 2012. At March 31, 2013, our allowance for doubtful accounts represented approximately 93% of the $5.179 billion total patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage or uninsured discounts was being evaluated.

Revenues increased 0.4% primarily due to the net impact of revenue per equivalent admission growth of 0.9% and a decline of 0.4% in equivalent admissions for the first quarter of 2013 compared to the first quarter of 2012. Same facility revenues increased 0.1% due to the net impact of a 0.8% increase in same facility revenue per equivalent admission and a 0.7% decline in same facility equivalent admissions for the first quarter of 2013 compared to the first quarter of 2012. The growth rate in revenues for the first quarter of 2013 compared to the first quarter of 2012 was reduced due to two adjustments (Rural Floor Provision Settlement and SSI ratios) related to Medicare revenues for prior periods. The net effect of the Medicare adjustments on 2012 revenues was an increase of $188 million.

Salaries and benefits, as a percentage of revenues, were 46.4% in the first quarter of 2013 and 44.5% in the first quarter of 2012. Salaries and benefits per equivalent admission increased 5.3% in the first quarter of 2013 compared to the first quarter of 2012. Same facility labor rate increases averaged 2.0% for the first quarter of 2013 compared to the first quarter of 2012.

34

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Quarters Ended March 31, 2013 and 2012 (continued)

Supplies, as a percentage of revenues, were 17.5% in the first quarter of 2013 and 16.9% in the first quarter of 2012. Supply cost per equivalent admission increased 4.7% in the first quarter of 2013 compared to the first quarter of 2012. Supply costs per equivalent admission increased 5.0% for medical devices, 1.1% for pharmacy supplies and 6.8% for general medical and surgical items in the first quarter of 2013 compared to the first quarter of 2012.

Other operating expenses, as a percentage of revenues, increased to 18.1% in the first quarter of 2013 from 17.6% in the first quarter of 2012. Other operating expenses is primarily comprised of contract services, professional fees, repairs and maintenance, rents and leases, utilities, insurance (including professional liability insurance) and nonincome taxes. Other operating expenses include $50 million and $80 million of indigent care costs in certain Texas markets during the first quarters of 2013 and 2012, respectively. Provisions for losses related to professional liability risks were $80 million and $94 million for the first quarters of 2013 and 2012, respectively.

We recognized $39 million and $55 million of electronic health record incentive income primarily related to Medicare during the first quarters of 2013 and 2012, respectively.

Equity in earnings of affiliates was $8 million and $11 million in the first quarters of 2013 and 2012, respectively.

Depreciation and amortization increased $7 million, from $417 million in the first quarter of 2012 to $424 million in the first quarter of 2013.

Interest expense increased from $442 million in the first quarter of 2012 to $472 million in the first quarter of 2013. The increase in interest expense was due to increases in both the average debt balance and average interest rate. Our average debt balance was $28.559 billion for the first quarter of 2013 compared to $27.537 billion for the first quarter of 2012. The average effective interest rate for our long term debt increased to 6.7% for the quarter ended March 31, 2013 from 6.5% for the quarter ended March 31, 2012.

During the first quarters of 2013 and 2012, we recorded net losses on sales of facilities of $16 million and $1 million, respectively.

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 7/8% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

The effective tax rates were 36.9% and 37.4% for the first quarters of 2013 and 2012, respectively. The effective tax rate computations exclude net income attributable to noncontrolling interests as it relates to consolidated partnerships.

35

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Quarters Ended March 31, 2013 and 2012 (continued)

Net income attributable to noncontrolling interests declined from $99 million for the first quarter of 2012 to $94 million for the first quarter of 2013.

Liquidity and Capital Resources

Cash provided by operating activities totaled $740 million in the first quarter of 2013 compared to $797 million in the first quarter of 2012. The $57 million decline in cash provided by operating activities in the first quarter of 2013 compared to the first quarter of 2012 related primarily to the net impact of the decline in net income of $168 million, excluding the losses on sales of facilities of $16 million and loss on retirement of debt of $17 million, partially offset by a positive impact from changes in working capital items of $50 million and a reduction of $50 million in income taxes. The combined interest payments and net tax refunds in the first quarters of 2013 and 2012 were $348 million and $492 million, respectively. Working capital totaled $1.796 billion at March 31, 2013 and $1.591 billion at December 31, 2012.

Cash used in investing activities was $373 million in the first quarter of 2013 compared to $437 million in the first quarter of 2012. Excluding acquisitions, capital expenditures were $404 million in the first quarter of 2013 and $335 million in the first quarter of 2012. We expended $22 million to acquire nonhospital health care facilities during the first quarter of 2013. We expended $58 million for the acquisition of a hospital facility and expended $54 million to acquire nonhospital health care facilities during the first quarter of 2012. Capital expenditures are expected to approximate $2.0 billion in 2013. At March 31, 2013, there were projects under construction which had estimated additional costs to complete and equip over the next five years of approximately $1.97 billion. We expect to finance capital expenditures with internally generated and borrowed funds. We received net cash flows from our investments of $51 million and $6 million in the first quarters of 2013 and 2012, respectively.

Cash used in financing activities totaled $478 million during the first quarter of 2013 compared to $262 million during the first quarter of 2012. During the first quarter of 2013, net cash flows used in financing activities included net debt repayments of $351 million, distributions to noncontrolling interests of $102 million, distributions to stockholders of $10 million and receipts of $36 million of income tax benefits for certain items (primarily related to employee exercises of stock options). During the first quarter of 2012, net cash flows used in financing activities included increases in net borrowings of $787 million, distributions to noncontrolling interests of $93 million, distributions to stockholders of $982 million, payments of debt issuance costs of $16 million and receipts of $49 million of income tax benefits for certain items (primarily distributions to holders of our stock options).

We are a highly leveraged company with significant debt service requirements. Our debt totaled $28.608 billion at March 31, 2013. Our interest expense was $472 million for the first quarter of 2013 and $442 million for the first quarter of 2012. The increase in interest expense was related to increases in both the average debt balance and average interest rate.

In addition to cash flows from operations, available sources of capital include amounts available under our senior secured credit facilities ($2.575 billion and $2.695 billion available as of March 31, 2013 and April 30, 2013, respectively) and anticipated access to public and private debt markets.

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 7/8% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

36

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Liquidity and Capital Resources (continued)

Investments of our professional liability insurance subsidiaries, to maintain statutory equity and pay claims, totaled $548 million and $570 million at March 31, 2013 and December 31, 2012, respectively. An insurance subsidiary maintained net reserves for professional liability risks of $320 million and $352 million at March 31, 2013 and December 31, 2012, respectively. Our facilities are insured by a wholly-owned insurance subsidiary for losses up to $50 million per occurrence; however, this coverage is subject to a $5 million per occurrence self-insured retention. Net reserves for the self-insured professional liability risks retained were $947 million and $896 million at March 31, 2013 and December 31, 2012, respectively. Claims payments, net of reinsurance recoveries, during the next 12 months are expected to approximate $312 million. We estimate that approximately $246 million of the expected net claim payments during the next 12 months will relate to claims subject to the self-insured retention.

Management believes that cash flows from operations, amounts available under our senior secured credit facilities and our anticipated access to public and private debt markets will be sufficient to meet expected liquidity needs during the next 12 months.

Market Risk

We are exposed to market risk related to changes in market values of securities. The investments in debt and equity securities of our wholly-owned insurance subsidiaries were $545 million and $3 million, respectively, at March 31, 2013. These investments are carried at fair value, with changes in unrealized gains and losses being recorded as adjustments to other comprehensive income. At March 31, 2013, we had a net unrealized gain of $18 million on the insurance subsidiaries’ investment securities.

We are exposed to market risk related to market illiquidity. Investments in debt and equity securities of our wholly-owned insurance subsidiaries could be impaired by the inability to access the capital markets. Should the wholly-owned insurance subsidiaries require significant amounts of cash in excess of normal cash requirements to pay claims and other expenses on short notice, we may have difficulty selling these investments in a timely manner or be forced to sell them at a price less than what we might otherwise have been able to in a normal market environment. At March 31, 2013, our wholly-owned insurance subsidiaries had invested $70 million ($74 million par value) in tax-exempt student loan auction rate securities that continue to experience market illiquidity. We may be required to recognize other-than-temporary impairments on our investment securities in future periods should issuers default on interest payments or should the fair market valuations of the securities deteriorate due to ratings downgrades or other issue specific factors.

We are also exposed to market risk related to changes in interest rates, and we periodically enter into interest rate swap agreements to manage our exposure to these fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives have been recognized in the financial statements at their respective fair values. Changes in the fair value of these derivatives, which are designated as cash flow hedges, are included in other comprehensive income, and changes in the fair value of derivatives which have not been designated as hedges are recorded in operations.

With respect to our interest-bearing liabilities, approximately $3.303 billion of long-term debt at March 31, 2013 was subject to variable rates of interest, while the remaining balance in long-term debt of $25.305 billion at March 31, 2013 was subject to fixed rates of interest. Both the general level of interest rates and, for the senior

37

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Liquidity and Capital Resources (continued)

Market Risk (continued)

secured credit facilities, our leverage affect our variable interest rates. Our variable debt is comprised primarily of amounts outstanding under the senior secured credit facilities. Borrowings under the senior secured credit facilities bear interest at a rate equal to an applicable margin plus, at our option, either (a) a base rate determined by reference to the higher of (1) the federal funds rate plus 0.50% and (2) the prime rate of Bank of America or (b) a LIBOR rate for the currency of such borrowing for the relevant interest period. The applicable margin for borrowings under the senior secured credit facilities may fluctuate according to a leverage ratio. The average effective interest rate for our long-term debt increased from 6.5% for the quarter ended March 31, 2012 to 6.7% for the quarter ended March 31, 2013.

The estimated fair value of our total long-term debt was $30.572 billion at March 31, 2013. The estimates of fair value are based upon the quoted market prices for the same or similar issues of long-term debt with the same maturities. Based on a hypothetical 1% increase in interest rates, the potential annualized reduction to future pretax earnings would be approximately $33 million. To mitigate the impact of fluctuations in interest rates, we generally target a portion of our debt portfolio to be maintained at fixed rates.

Our international operations and the European term loan expose us to market risks associated with foreign currencies. In order to mitigate the currency exposure related to debt service obligations under the European term loan, we have entered into a cross currency swap agreement. A cross currency swap is an agreement between two parties to exchange a stream of principal and interest payments in one currency for a stream of principal and interest payments in another currency over a specified period. Our credit risk related to this agreement is considered low because the swap agreement is with a creditworthy financial institution.

IRS Examinations

We expect the IRS Examination Division will begin an audit of HCA Holdings, Inc.’s 2010 and 2011 federal income tax returns in 2013.

Management believes HCA Holdings, Inc. and its affiliates properly reported taxable income and paid taxes in accordance with applicable laws and agreements established with the IRS and final resolution of any disputes will not have a material, adverse effect on our results of operations or financial position. However, if payments due upon final resolution of any issues exceed our recorded estimates, such resolutions could have a material, adverse effect on our results of operations or financial position.

38

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Operating Data

	2013		2012
Number of hospitals in operation at:
March 31		162		164
June 30				163
September 30				162
December 31				162
Number of freestanding outpatient surgical centers in operation at:
March 31		113		109
June 30				110
September 30				112
December 31				112
Licensed hospital beds at(a):
March 31		41,891		41,815
June 30				41,817
September 30				41,884
December 31				41,804
Weighted average licensed beds(b):
Quarter:
First		41,867		41,740
Second				41,789
Third				41,873
Fourth				41,777
Year				41,795
Average daily census(c):
Quarter:
First		24,147		23,284
Second				22,113
Third				22,122
Fourth				22,567
Year				22,521
Admissions(d):
Quarter:
First		444,200		443,300
Second				428,200
Third				430,500
Fourth				438,700
Year				1,740,700
Equivalent admissions(e):
Quarter:
First		708,000		711,100
Second				700,800
Third				705,200
Fourth				715,000
Year				2,832,100

39

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Operating Data—(continued)

	2013			2012
Average length of stay (days)(f):
Quarter:
First		4.9			4.8
Second					4.7
Third					4.7
Fourth					4.7
Year					4.7
Emergency room visits(g):
Quarter:
First		1,749,300			1,688,400
Second					1,714,200
Third					1,724,000
Fourth					1,785,400
Year					6,912,000
Outpatient surgeries(h):
Quarter:
First		211,100			217,500
Second					219,800
Third					212,300
Fourth					224,000
Year					873,600
Inpatient surgeries(i):
Quarter:
First		124,700			128,300
Second					126,700
Third					124,700
Fourth					126,800
Year					506,500
Days revenues in accounts receivable(j):
Quarter:
First		52			53
Second					50
Third					52
Fourth					51
Year					52
Gross patient revenues(k) (dollars in millions):
Quarter:
First	$	44,791		$	41,377
Second					40,327
Third					40,125
Fourth					43,785
Year					165,614
Outpatient revenues as a % of patient revenues(l):
Quarter:
First		37	%		37	%
Second					39	%
Third					38	%
Fourth					39	%
Year					38	%

40

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Operating Data—(continued)

BALANCE SHEET DATA

	% of Accounts Receivable
	Under 91 Days			91 — 180 Days			Over 180 Days
Accounts receivable aging at March 31, 2013 (m):
Medicare and Medicaid		14	%		2	%		1	%
Managed care and other discounted		22			4			4
Uninsured		16			8			29
Total		52	%		14	%		34	%

(a) Licensed beds are those beds for which a facility has been granted approval to operate from the applicable state licensing agency.

(b) Represents the average number of licensed beds, weighted based on periods owned.

(c) Represents the average number of patients in our hospital beds each day.

(d) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(e) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenues and gross outpatient revenues and then dividing the resulting amount by gross inpatient revenues. The equivalent admissions computation “equates” outpatient revenues to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume.

(f) Represents the average number of days admitted patients stay in our hospitals.

(g) Represents the number of patients treated in our emergency rooms.

(h) Represents the number of surgeries performed on patients who were not admitted to our hospitals. Pain management and endoscopy procedures are not included in outpatient surgeries.

(i) Represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management and endoscopy procedures are not included in inpatient surgeries.

(j) Revenues per day is calculated by dividing the revenues for the period by the days in the period. Days revenues in accounts receivable is then calculated as accounts receivable, net of allowance for doubtful accounts, at the end of the period divided by the revenues per day.

(k) Gross patient revenues are based upon our standard charge listing. Gross charges/revenues typically do not reflect what our hospital facilities are paid. Gross charges/revenues are reduced by contractual adjustments, discounts and charity care to determine reported revenues.

(l) Represents the percentage of patient revenues related to patients who are not admitted to our hospitals.

(m) Accounts receivable aging data is based upon consolidated gross accounts receivable of $9.673 billion (each 1% is equivalent to approximately $97 million of gross accounts receivable).

41

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The information called for by this item is provided under the caption “Market Risk” under Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

HCA’s chief executive officer and chief financial officer have reviewed and evaluated the effectiveness of HCA’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”)) as of the end of the period covered by this quarterly report. Based on that evaluation, the chief executive officer and chief financial officer have concluded HCA’s disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

During the period covered by this report, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. The resolution of any such lawsuits, claims or legal and regulatory proceedings could materially and adversely affect our results of operations and financial position in a given period.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

As initially disclosed in 2010, the DOJ has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

42

In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other than peer reviews). The Company is cooperating with the government’s request and is currently producing medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.

New Hampshire Hospital Litigation

In 2006, the Foundation for Seacoast Health (the “Foundation”) filed suit against HCA in state court in New Hampshire. The Foundation alleged that both the 2006 recapitalization transaction and a prior 1999 intra-corporate transaction violated a 1983 agreement that placed certain restrictions on transfers of the Portsmouth Regional Hospital. In May 2007, the trial court ruled against the Foundation on all its claims. On appeal, the New Hampshire Supreme Court affirmed the ruling on the 2006 recapitalization, but remanded to the trial court the claims based on the 1999 intra-corporate transaction. The trial court ruled in December 2009 that the 1999 intra-corporate transaction breached the transfer restriction provisions of the 1983 agreement. In September of 2011, the trial court issued its remedies phase decision and held that the only remedy to which the Foundation was entitled was rescission of the intra-corporate transfer that breached the transfer restriction (the Company has complied with the Court’s order, and it is not expected that such compliance will have any material effect on our operations or financial position). The Court awarded the Foundation, under the terms of the Asset Purchase Agreement, a “fraction” of its attorney fees. The Foundation appealed the remedy phase ruling, and the Company cross-appealed the liability determination. On October 31, 2011, the New Hampshire Supreme Court, on its own, raised the question whether the appeal needed to await the trial court’s further ruling on attorney fees. On November 21, 2011, after the parties briefed the issue, the New Hampshire Supreme Court dismissed the appeal as premature and remanded the case to the trial court. In February 2012, the trial court certified the case for a possible interlocutory appeal without addressing the attorney fees issue. The New Hampshire Supreme Court rejected the request for an interlocutory appeal. The parties subsequently reached a stipulation regarding the attorney fees. The trial court accepted the parties’ stipulation regarding attorneys fees and entered final judgment on liability and remedies on May 4, 2012. Both sides filed appeals with the New Hampshire Supreme Court, and briefing was completed in early February 2013. Oral argument has been scheduled, and a decision on appeal is anticipated mid-to-late 2013.

Securities Class Action Litigation

On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010 reorganization; (2) the Company’s failure

43

to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court heard argument on the motion in April 2013. A decision on the motion is anticipated mid-to-late 2013.

In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions have been consolidated in the Middle District of Tennessee, and the parties have agreed that those cases shall be stayed pending developments in the shareholder class actions. The state derivative action has also been stayed pending developments in the shareholder class actions.

Health Midwest Litigation

In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. Should the accounting fail to satisfy the Court concerning HCA’s compliance with its capital and charity care commitments, the amount of the judgment award could substantially increase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are about $12 million. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling; however, the Company plans to appeal the ruling.

General Liability and Other Claims

We are subject to claims for additional income taxes and related interest. For a description of those proceedings, see Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — IRS Examinations” and Note 3 to our condensed consolidated financial statements.

We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or for wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants have asked for punitive damages against us, which may not be covered by insurance. In the opinion of management, the ultimate resolution of these pending claims and legal proceedings will not have a material, adverse effect on our results of operations or financial position.

ITEM 1A: RISK FACTORS

Reference is made to the factors set forth under the caption “Forward-Looking Statements” in Part I, Item 2 of this Form 10-Q and other risk factors described in our annual report on Form 10-K for the year ended December 31, 2012, which are incorporated herein by reference. There have not been any material changes to the risk factors previously disclosed in our annual report on Form 10-K for the year ended December 31, 2012.

44

ITEM 6. EXHIBITS

(a) List of Exhibits:

10.1	—	Second Amendment to the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as amended and restated.*
31.1	—	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	—	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	—	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	—	The following financial information from our quarterly report on Form 10-Q for the quarters ended March 31, 2013 and 2012, filed with the SEC on May 7, 2013, formatted in Extensible Business Reporting Language (XBRL): (i) the condensed consolidated balance sheets at March 31, 2013 and December 31, 2012, (ii) the condensed consolidated income statements for the quarters ended March 31, 2013 and 2012, (iii) the condensed consolidated comprehensive income statements for the quarters ended March 31, 2013 and 2012, (iv) the condensed consolidated statements of cash flows for the quarters ended March 31, 2013 and 2012 and (v) the notes to condensed consolidated financial statements.(1)

(1) The XBRL related information in Exhibit 101 to this quarterly report on Form 10-Q shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

* Management compensatory plan or arrangement.

45

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

HCA Holdings, Inc.
By:	/S/    R. MILTON JOHNSON
	R. Milton Johnson
	President and Chief Financial Officer

Date: May 7, 2013

46

EX-10.1

Exhibit 10.1

Second Amendment to the

2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates,

as amended and restated

Effective as of February 1, 2013

WHEREAS, HCA Holdings, Inc. (the “Company”) has previously adopted the 2006 Stock Incentive Plan for Key Employees of HCA Holdings Inc. and its Affiliates, as amended and restated (the “Plan”); and

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it would be advisable and in the best interests of the Company and its stockholders to amend the Plan as provided below to allow the Compensation Committee (the “Committee”) of the Board to delegate to the Chief Executive Officer of the Company the authority to make grants to certain participants in the Plan subject to the terms and limitations of the Plan and such conditions and limitations as the Committee shall prescribe;

NOW, THEREFORE, the Plan is hereby amended as follows, effective as of the date first written above:

1. Section 3(a) of the Plan is hereby amended by deleting the last sentence of such section in its entirety and inserting the following in lieu thereof:

“The Committee may, by resolution, delegate to the Chief Executive Officer of the Company its duties under the Plan, subject to applicable law, the terms and limitations of the Plan, and such conditions and limitations as the Committee shall prescribe, including the authority, within specified parameters, to (i) designate Employees to be recipients of Grants (excluding Grants in the form of an award of Shares or restricted Shares) under the Plan, and (ii) to determine the number of such Grants (excluding Grants in the form of an award of Shares or restricted Shares) to be received by any such Participants; provided, however, that such delegation of duties and responsibilities to an officer of the Company may not be made with respect to Grants to eligible participants (a) who are subject to Section 16(a) of the Exchange Act at the time of grant, or (b) who are at the time of grant, or are anticipated to be become during the term of the Grants, “covered employees” as defined in Section 162(m)(3) of the Code.”

2. All other provisions of the Plan and the Grant Agreements shall remain in full force and effect, except to the extent modified by the foregoing.

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Richard M. Bracken, certify that:

1. I have reviewed this quarterly report on Form 10-Q of HCA Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/    RICHARD M. BRACKEN
	RICHARD M. BRACKEN
	Chairman of the Board and Chief Executive Officer

Date: May 7, 2013

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, R. Milton Johnson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of HCA Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/S/    R. MILTON JOHNSON
	R. MILTON JOHNSON
	President and Chief Financial Officer

Date: May 7, 2013

EX-32

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of HCA Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/    RICHARD M. BRACKEN
	RICHARD M. BRACKEN
	Chairman of the Board and Chief Executive Officer

May 7, 2013

By:	/s/    R. MILTON JOHNSON
	R. MILTON JOHNSON
	President and Chief Financial Officer

May 7, 2013

XML

FINANCIAL INSTRUMENTS - Schedule of Cross Currency Swap Agreement Not Designated as Hedge (Detail) (Euro - United States Dollar Currency Swap [Member], Maturity Date, November 2013 [Member]) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013 USD ($)	Mar. 31, 2013 EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]
Notional amount for foreign currency derivatives		€ 241
Maturity Date	Nov. 30, 2013	Nov. 30, 2013
Fair Value	$ (22)

XML

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION - Schedule of Condensed Consolidating Comprehensive Income Statement (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts	$ 9,194	$ 9,199
Provision for doubtful accounts	754	794
Revenues	8,440	8,405
Salaries and benefits	3,917	3,736
Supplies	1,479	1,419
Other operating expenses	1,523	1,493
Electronic health record incentive income	(39)	(55)
Equity in earnings of affiliates	(8)	(11)
Depreciation and amortization	424	417
Interest expense	472	442
Gain/Loss on sales of facilities	16	1
Loss on retirement of debt	17
Management fees
Total expenses including equity in earnings of a affiliates	7,801	7,442
Income (loss) before income taxes	639	963
Provision (benefit) for income taxes	201	324
Net income (loss)	438	639
Net income attributable to non controlling interests	94	99
Net income (loss) attributable to HCA Holdings, Inc.	344	540
Comprehensive income (loss) attributable to HCA Holdings, Inc.	326	569
HCA Holdings, Inc. Issuer [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts
Provision for doubtful accounts
Revenues
Salaries and benefits
Supplies
Other operating expenses	1
Electronic health record incentive income
Equity in earnings of affiliates	(356)	(560)
Depreciation and amortization
Interest expense	46	30
Gain/Loss on sales of facilities
Loss on retirement of debt
Management fees
Total expenses including equity in earnings of a affiliates	(309)	(530)
Income (loss) before income taxes	309	530
Provision (benefit) for income taxes	(17)	(10)
Net income (loss)	326	540
Net income attributable to non controlling interests
Net income (loss) attributable to HCA Holdings, Inc.	326	540
Comprehensive income (loss) attributable to HCA Holdings, Inc.	326	540
HCA Inc. Issuer [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts
Provision for doubtful accounts
Revenues
Salaries and benefits
Supplies
Other operating expenses		4
Electronic health record incentive income
Equity in earnings of affiliates
Depreciation and amortization
Interest expense	558	529
Gain/Loss on sales of facilities
Loss on retirement of debt	17
Management fees
Total expenses including equity in earnings of a affiliates	575	533
Income (loss) before income taxes	(575)	(533)
Provision (benefit) for income taxes	(212)	(200)
Net income (loss)	(363)	(333)
Net income attributable to non controlling interests
Net income (loss) attributable to HCA Holdings, Inc.	(363)	(333)
Comprehensive income (loss) attributable to HCA Holdings, Inc.	(347)	(329)
Subsidiary Guarantors [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts	4,872	4,903
Provision for doubtful accounts	443	463
Revenues	4,429	4,440
Salaries and benefits	2,127	1,982
Supplies	791	753
Other operating expenses	732	729
Electronic health record incentive income	(29)	(41)
Equity in earnings of affiliates	(1)	(2)
Depreciation and amortization	209	200
Interest expense	(106)	(91)
Gain/Loss on sales of facilities	16	1
Loss on retirement of debt
Management fees	(183)	(160)
Total expenses including equity in earnings of a affiliates	3,556	3,371
Income (loss) before income taxes	873	1,069
Provision (benefit) for income taxes	317	392
Net income (loss)	556	677
Net income attributable to non controlling interests	13	17
Net income (loss) attributable to HCA Holdings, Inc.	543	660
Comprehensive income (loss) attributable to HCA Holdings, Inc.	547	664
Subsidiary Non-Guarantors [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts	4,322	4,296
Provision for doubtful accounts	311	331
Revenues	4,011	3,965
Salaries and benefits	1,790	1,754
Supplies	688	666
Other operating expenses	790	760
Electronic health record incentive income	(10)	(14)
Equity in earnings of affiliates	(7)	(9)
Depreciation and amortization	215	217
Interest expense	(26)	(26)
Gain/Loss on sales of facilities
Loss on retirement of debt
Management fees	183	160
Total expenses including equity in earnings of a affiliates	3,623	3,508
Income (loss) before income taxes	388	457
Provision (benefit) for income taxes	113	142
Net income (loss)	275	315
Net income attributable to non controlling interests	81	82
Net income (loss) attributable to HCA Holdings, Inc.	194	233
Comprehensive income (loss) attributable to HCA Holdings, Inc.	156	254
Eliminations [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts
Provision for doubtful accounts
Revenues
Salaries and benefits
Supplies
Other operating expenses
Electronic health record incentive income
Equity in earnings of affiliates	356	560
Depreciation and amortization
Interest expense
Gain/Loss on sales of facilities
Loss on retirement of debt
Management fees
Total expenses including equity in earnings of a affiliates	356	560
Income (loss) before income taxes	(356)	(560)
Provision (benefit) for income taxes
Net income (loss)	(356)	(560)
Net income attributable to non controlling interests
Net income (loss) attributable to HCA Holdings, Inc.	(356)	(560)
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$ (356)	$ (560)

XML

CAPITAL STRUCTURE - Schedule of Changes in Stockholders' Deficit and Equity (Detail) (USD $) In Millions, except Share data in Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Capital Structure [Line Items]
Beginning Balance	$ (8,341)
Net income	438	639
Other comprehensive loss	(18)
Distributions	(102)
Share-based benefit plans	15
Other	(4)
Ending Balance	(8,012)
Common Stock [Member]
Capital Structure [Line Items]
Beginning Balance	4
Net income
Other comprehensive loss
Distributions
Share-based benefit plans
Other
Ending Balance	4
Beginning Balance, Shares	443,200
Share-based benefit plans, Shares	2,656
Ending Balance, Shares	445,856
Capital in Excess of Par Value [Member]
Capital Structure [Line Items]
Beginning Balance	1,753
Net income
Other comprehensive loss
Distributions
Share-based benefit plans	15
Other	(4)
Ending Balance	1,764
Accumulated Other Comprehensive Loss [Member]
Capital Structure [Line Items]
Beginning Balance	(457)
Net income
Other comprehensive loss	(18)
Distributions
Share-based benefit plans
Other
Ending Balance	(475)
Retained Deficit [Member]
Capital Structure [Line Items]
Beginning Balance	(10,960)
Net income	344
Other comprehensive loss
Distributions
Share-based benefit plans
Other
Ending Balance	(10,616)
Equity Attributable to Noncontrolling Interests [Member]
Capital Structure [Line Items]
Beginning Balance	1,319
Net income	94
Other comprehensive loss
Distributions	(102)
Share-based benefit plans
Other
Ending Balance	$ 1,311

XML

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION - Schedule of Condensed Consolidating Balance Sheet (Detail) (USD $) In Millions, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 594	$ 705	$ 471	$ 373
Accounts receivable, net	4,877	4,672
Inventories	1,104	1,086
Deferred income taxes	385	385
Other	827	915
Total current assets	7,787	7,763
Property and equipment, net	13,144	13,185
Investments of insurance subsidiaries	423	515
Investments in and advances to affiliates	107	104
Goodwill and other intangible assets	5,541	5,539
Deferred loan costs	274	290
Other	606	679
Total assets	27,882	28,075
Current liabilities:
Accounts payable	1,691	1,768
Accrued salaries	969	1,120
Other accrued expenses	1,893	1,849
Long-term debt due within one year	1,438	1,435
Total current liabilities	5,991	6,172
Long-term debt	27,170	27,495
Intercompany balances	0
Professional liability risks	970	973
Income taxes and other liabilities	1,763	1,776
Total liabilities	35,894	36,416
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(9,323)	(9,660)
Non controlling interests	1,311	1,319
Total stockholders' deficit	(8,012)	(8,341)
Total liabilities and stockholders' deficit	27,882	28,075
HCA Holdings, Inc. Issuer [Member]
Current assets:
Cash and cash equivalents	1	22
Accounts receivable, net	0
Inventories	0
Deferred income taxes	385	385
Other	0	122
Total current assets	386	529
Property and equipment, net	0
Investments of insurance subsidiaries	0
Investments in and advances to affiliates	18,837	18,481
Goodwill and other intangible assets	0
Deferred loan costs	32	32
Other	396	469
Total assets	19,651	19,511
Current liabilities:
Accounts payable	1
Accrued salaries	0
Other accrued expenses	247	30
Long-term debt due within one year	0
Total current liabilities	248	30
Long-term debt	2,525	2,525
Intercompany balances	25,750	26,131
Professional liability risks	0
Income taxes and other liabilities	451	485
Total liabilities	28,974	29,171
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(9,323)	(9,660)
Non controlling interests	0
Total stockholders' deficit	(9,323)	(9,660)
Total liabilities and stockholders' deficit	19,651	19,511
HCA Inc. Issuer [Member]
Current assets:
Cash and cash equivalents	0
Accounts receivable, net	0
Inventories	0
Deferred income taxes	0
Other	0
Total current assets	0
Property and equipment, net	0
Investments of insurance subsidiaries	0
Investments in and advances to affiliates	0
Goodwill and other intangible assets	0
Deferred loan costs	242	258
Other	0
Total assets	242	258
Current liabilities:
Accounts payable	0
Accrued salaries	0
Other accrued expenses	454	567
Long-term debt due within one year	1,363	1,360
Total current liabilities	1,817	1,927
Long-term debt	23,988	24,304
Intercompany balances	(11,633)	(12,407)
Professional liability risks	0
Income taxes and other liabilities	425	442
Total liabilities	14,597	14,266
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(14,355)	(14,008)
Non controlling interests	0
Total stockholders' deficit	(14,355)	(14,008)
Total liabilities and stockholders' deficit	242	258
Subsidiary Guarantors [Member]
Current assets:
Cash and cash equivalents	272	383	144	115
Accounts receivable, net	2,503	2,448
Inventories	647	629
Deferred income taxes	0
Other	317	342
Total current assets	3,739	3,802
Property and equipment, net	7,444	7,417
Investments of insurance subsidiaries	0
Investments in and advances to affiliates	16	16
Goodwill and other intangible assets	1,697	1,697
Deferred loan costs	0
Other	25	31
Total assets	12,921	12,963
Current liabilities:
Accounts payable	1,126	1,203
Accrued salaries	569	638
Other accrued expenses	400	464
Long-term debt due within one year	40	39
Total current liabilities	2,135	2,344
Long-term debt	173	173
Intercompany balances	(17,525)	(17,130)
Professional liability risks	0
Income taxes and other liabilities	652	629
Total liabilities	(14,565)	(13,984)
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	27,394	26,847
Non controlling interests	92	100
Total stockholders' deficit	27,486	26,947
Total liabilities and stockholders' deficit	12,921	12,963
Subsidiary Non-Guarantors [Member]
Current assets:
Cash and cash equivalents	321	300	327	258
Accounts receivable, net	2,374	2,224
Inventories	457	457
Deferred income taxes	0
Other	510	451
Total current assets	3,662	3,432
Property and equipment, net	5,700	5,768
Investments of insurance subsidiaries	423	515
Investments in and advances to affiliates	91	88
Goodwill and other intangible assets	3,844	3,842
Deferred loan costs	0
Other	185	179
Total assets	13,905	13,824
Current liabilities:
Accounts payable	564	565
Accrued salaries	400	482
Other accrued expenses	792	788
Long-term debt due within one year	35	36
Total current liabilities	1,791	1,871
Long-term debt	484	493
Intercompany balances	3,408	3,406
Professional liability risks	970	973
Income taxes and other liabilities	235	220
Total liabilities	6,888	6,963
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	5,798	5,642
Non controlling interests	1,219	1,219
Total stockholders' deficit	7,017	6,861
Total liabilities and stockholders' deficit	13,905	13,824
Eliminations [Member]
Current assets:
Cash and cash equivalents	0
Accounts receivable, net	0
Inventories	0
Deferred income taxes	0
Other	0
Total current assets	0
Property and equipment, net	0
Investments of insurance subsidiaries	0
Investments in and advances to affiliates	(18,837)	(18,481)
Goodwill and other intangible assets	0
Deferred loan costs	0
Other	0
Total assets	(18,837)	(18,481)
Current liabilities:
Accounts payable	0
Accrued salaries	0
Other accrued expenses	0
Long-term debt due within one year	0
Total current liabilities	0
Long-term debt	0
Intercompany balances	0
Professional liability risks	0
Income taxes and other liabilities	0
Total liabilities	0
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(18,837)	(18,481)
Non controlling interests	0
Total stockholders' deficit	(18,837)	(18,481)
Total liabilities and stockholders' deficit	$ (18,837)	$ (18,481)

XML

LONG-TERM DEBT - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Proforma Debt Instrument [Line Items]
Pretax loss on retirement of debt	$ 17
Senior Secured Second Lien Notes Due 2017 [Member]
Proforma Debt Instrument [Line Items]
Redemption of aggregate principal amount	$ 201
Debt instrument , Stated interest	9.875%
Percentage of Redemption of principal amount	104.938%

XML

EARNINGS PER SHARE - Schedule of Computations of Basic and Diluted Earnings Per Share (Detail) (USD $) In Millions, except Share data in Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Earnings Per Share [Line Items]
Net income attributable to HCA Holdings, Inc.	$ 344	$ 540
Weighted average common shares outstanding	444,401	437,936
Effect of dilutive incremental shares	17,967	20,376
Shares used for diluted earnings per share	462,368	458,312
Basic earnings per share	$ 0.77	$ 1.23
Diluted earnings per share	$ 0.74	$ 1.18

XML

LONG-TERM DEBT (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of Long-Term Debt

A summary of long-term debt at March 31, 2013 and December 31, 2012, including related interest rates at March 31, 2013, follows (dollars in millions):

	March 31, 2013		December 31, 2012
Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	1,860	$	1,470
Senior secured revolving credit facility		—		—
Senior secured term loan facilities (effective interest rate of 5.6%)		5,941		5,958
Senior secured first lien notes (effective interest rate of 7.1%)		9,689		9,688
Other senior secured debt (effective interest rate of 7.0%)		424		423
First lien debt		17,914		17,539
Senior secured second lien notes		—		197
Senior unsecured notes (effective interest rate of 7.2%)		10,694		11,194
Total debt (average life of 6.9 years, rates averaging 6.5%)		28,608		28,930
Less amounts due within one year		1,438		1,435
	$	27,170	$	27,495

XML

CAPITAL STRUCTURE - Components of Accumulated Other Comprehensive Loss (Parenthetical) (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013
Accumulated Other Comprehensive Income Loss [Line Items]
Foreign currency translation adjustments, income (taxes)	$ 21
Change in fair value of derivative instruments, income tax benefit	3
Defined benefit plan, (income) expense reclassified into operations from other comprehensive income, Tax portion	3
Change in fair value of derivative instruments, (income) expense reclassified into other comprehensive income, Tax Portion	$ 12

XML

ASSETS AND LIABILITIES MEASURED AT FAIR VALUE - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) (USD $) In Millions, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	$ 548	$ 570
Less amounts classified as current assets	(125)	(55)
Investments of insurance subsidiaries, noncurrent	423	515
Cross currency swap (Income taxes and other liabilities) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	22
Interest rate swaps [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	403	429
Cross currency swap [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value		13
Auction rate securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	70
Equity securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	3	3
Debt securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	545	567
Debt securities [Member] | States and municipalities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	412	418
Debt securities [Member] | Auction rate securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	70	68
Debt securities [Member] | Asset-backed securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	12	14
Debt securities [Member] | Money market funds [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	51	67
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	53	68
Less amounts classified as current assets	(51)	(55)
Investments of insurance subsidiaries, noncurrent	2	13
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Equity securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	2	1
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	51	67
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt securities [Member] | Money market funds [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	51	67
Significant Other Observable Inputs (Level 2) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	424	432
Less amounts classified as current assets	(74)
Investments of insurance subsidiaries, noncurrent	350	432
Significant Other Observable Inputs (Level 2) [Member] | Cross currency swap (Income taxes and other liabilities) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	22
Significant Other Observable Inputs (Level 2) [Member] | Interest rate swaps [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	403	429
Significant Other Observable Inputs (Level 2) [Member] | Cross currency swap [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value		13
Significant Other Observable Inputs (Level 2) [Member] | Debt securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	424	432
Significant Other Observable Inputs (Level 2) [Member] | Debt securities [Member] | States and municipalities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	412	418
Significant Other Observable Inputs (Level 2) [Member] | Debt securities [Member] | Asset-backed securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	12	14
Significant Unobservable Inputs (Level 3) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	71	70
Investments of insurance subsidiaries, noncurrent	71	70
Significant Unobservable Inputs (Level 3) [Member] | Equity securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	1	2
Significant Unobservable Inputs (Level 3) [Member] | Debt securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	70	68
Significant Unobservable Inputs (Level 3) [Member] | Debt securities [Member] | Auction rate securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	$ 70	$ 68

XML

FINANCIAL INSTRUMENTS - Schedule of Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) (Pay-fixed interest rate swaps [Member], USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013
Maturity Date, 2014 [Member]
Derivative Instruments [Line Items]
Fair Value	$ (8)
Pay-fixed interest rate swaps	Dec. 31, 2014
Notional Amount	500
Maturity Date, 2016 [Member]
Derivative Instruments [Line Items]
Fair Value	(326)
Pay-fixed interest rate swaps	Dec. 31, 2016
Notional Amount	3,000
Maturity Date, 2017 [Member]
Derivative Instruments [Line Items]
Fair Value	(69)
Pay-fixed interest rate swaps	Dec. 31, 2017
Notional Amount	$ 1,000

XML

SEGMENT AND GEOGRAPHIC INFORMATION - Schedule of Geographic Distributions of Revenues, Equity in Earnings of Affiliates, Adjusted Segment Ebitda, Depreciation and Amortization and Assets (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Segment Reporting Information [Line Items]
Revenues	$ 8,440	$ 8,405
Equity in earnings of affiliates	(8)	(11)
Adjusted segment EBITDA	1,568	1,823
Depreciation and amortization	424	417
Interest expense	472	442
Losses on sales of facilities	16	1
Loss on retirement of debt	17
Income before income taxes	639	963
National Group [Member]
Segment Reporting Information [Line Items]
Revenues	3,981	3,992
Equity in earnings of affiliates	(2)	(4)
Adjusted segment EBITDA	804	921
Depreciation and amortization	174	173
American Group [Member]
Segment Reporting Information [Line Items]
Revenues	4,034	4,085
Equity in earnings of affiliates	(6)	(7)
Adjusted segment EBITDA	828	973
Depreciation and amortization	202	203
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Revenues	425	328
Equity in earnings of affiliates
Adjusted segment EBITDA	64	71
Depreciation and amortization	$ 48	$ 41

XML

CONTINGENCIES AND LEGAL CLAIM COSTS - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	12 Months Ended				0 Months Ended
	Dec. 31, 2012 Y	Mar. 31, 2013 Hospital	Oct. 28, 2011 Cases	Dec. 31, 2003	Jan. 24, 2013 Pending Litigation [Member] Health Care Foundation of Greater Kansas City [Member]	Jul. 31, 2012 Florida [Member] Hospital
Schedule Of Activities Related To Claims Filed [Line Items]
Number of owned and operated hospitals reviewed		95				8
Number of claims filed			3
Capital commitments in connection with purchase of hospitals				$ 450
Legal claim costs	175
Judgment award by the court					162
Period of agreed capital commitments	5 years
Number of year under court-supervisor accounting for expenditures following the purchase	10
Plaintiff attorneys fees award					$ 12

XML

INCOME TAXES

3 Months Ended

Mar. 31, 2013

INCOME TAXES

NOTE 3 — INCOME TAXES

During the quarter ended March 31, 2013, we finalized settlements with the IRS resolving all outstanding issues for HCA Inc.’s 2007, 2008 and 2009 tax years. We expect the IRS Examination Division will begin an audit of HCA Holdings, Inc.’s 2010 and 2011 federal income tax returns in 2013.

Our liability for unrecognized tax benefits was $416 million, including accrued interest of $14 million, as of March 31, 2013 ($426 million and $14 million, respectively, as of December 31, 2012). Unrecognized tax benefits of $127 million ($125 million as of December 31, 2012) would affect the effective rate, if recognized. The provision for income taxes reflects $18 million and $3 million ($11 million and $2 million, respectively, net of tax) of reductions in interest expense related to taxing authority examinations for the quarters ended March 31, 2013 and 2012, respectively.

Depending on the completion of examinations by federal, state or international taxing authorities, the resolution of any tax disputes, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible our liability for unrecognized tax benefits may significantly increase or decline within the next 12 months. However, we are currently unable to estimate the range of any possible change.

XML

ASSETS AND LIABILITIES MEASURED AT FAIR VALUE - Schedule Related to Auction Rate and Equity Securities Investments of Insurance Subsidiaries at Fair Value (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013
Asset, Beginning Balance	$ 70
Unrealized gains included in other comprehensive income	1
Asset, Ending Balance	$ 71

XML

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Additional Information (Detail) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013 State	Mar. 31, 2012	Mar. 31, 2011
Summary Of Significant Accounting Policies [Line Items]
Initial public offering of shares common stock			87,719,300
Number of owned and operated hospitals	162
Number of freestanding surgery centers	113
Number of facilities locations	20
General and administrative expense	$ 66	$ 53
Adjustments to Medicare revenues		188
Adjustment and related expenses added to income before income taxes		170
Adjustment and related expenses added to income before income taxes in diluted per share		$ 0.22
Rural Floor Provision Settlement Effect [Member]
Summary Of Significant Accounting Policies [Line Items]
Adjustments to Medicare revenues		271
Implementation of Revised Supplemental Security Income Ratios [Member]
Summary Of Significant Accounting Policies [Line Items]
Adjustments to Medicare revenues		$ 83

XML

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of Condensed Consolidating Comprehensive Income Statement

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED MARCH 31, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,872		$	4,322		$	—		$	9,194
Provision for doubtful accounts		—			—			443			311			—			754
Revenues		—			—			4,429			4,011			—			8,440
Salaries and benefits		—			—			2,127			1,790			—			3,917
Supplies		—			—			791			688			—			1,479
Other operating expenses		1			—			732			790			—			1,523
Electronic health record incentive income		—			—			(29	)		(10	)		—			(39	)
Equity in earnings of affiliates		(356	)		—			(1	)		(7	)		356			(8	)
Depreciation and amortization		—			—			209			215			—			424
Interest expense		46			558			(106	)		(26	)		—			472
Losses on sales of facilities		—			—			16			—			—			16
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(183	)		183			—			—
		(309	)		575			3,556			3,623			356			7,801
Income (loss) before income taxes		309			(575	)		873			388			(356	)		639
Provision (benefit) for income taxes		(17	)		(212	)		317			113			—			201
Net income (loss)		326			(363	)		556			275			(356	)		438
Net income attributable to noncontrolling interests		—			—			13			81			—			94
Net income (loss) attributable to HCA Holdings, Inc.	$	326		$	(363	)	$	543		$	194		$	(356	)	$	344
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	326		$	(347	)	$	547		$	156		$	(356	)	$	326

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED MARCH 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,903		$	4,296		$	—		$	9,199
Provision for doubtful accounts		—			—			463			331			—			794
Revenues		—			—			4,440			3,965			—			8,405
Salaries and benefits		—			—			1,982			1,754			—			3,736
Supplies		—			—			753			666			—			1,419
Other operating expenses		—			4			729			760			—			1,493
Electronic health record incentive income		—			—			(41	)		(14	)		—			(55	)
Equity in earnings of affiliates		(560	)		—			(2	)		(9	)		560			(11	)
Depreciation and amortization		—			—			200			217			—			417
Interest expense		30			529			(91	)		(26	)		—			442
Losses on sales of facilities		—			—			1			—			—			1
Management fees		—			—			(160	)		160			—			—
		(530	)		533			3,371			3,508			560			7,442
Income (loss) before income taxes		530			(533	)		1,069			457			(560	)		963
Provision (benefit) for income taxes		(10	)		(200	)		392			142			—			324
Net income (loss)		540			(333	)		677			315			(560	)		639
Net income attributable to noncontrolling interests		—			—			17			82			—			99
Net income (loss) attributable to HCA Holdings, Inc.	$	540		$	(333	)	$	660		$	233		$	(560	)	$	540
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	540		$	(329	)	$	664		$	254		$	(560	)	$	569

Schedule of Condensed Consolidating Balance Sheet

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

MARCH 31, 2013

(Dollars in millions)

	HCA Holdings,  Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	1		$	—		$	272		$	321	$	—		$	594
Accounts receivable, net		—			—			2,503			2,374		—			4,877
Inventories		—			—			647			457		—			1,104
Deferred income taxes		385			—			—			—		—			385
Other		—			—			317			510		—			827
		386			—			3,739			3,662		—			7,787
Property and equipment, net		—			—			7,444			5,700		—			13,144
Investments of insurance subsidiaries		—			—			—			423		—			423
Investments in and advances to affiliates		18,837			—			16			91		(18,837)			107
Goodwill and other intangible assets		—			—			1,697			3,844		—			5,541
Deferred loan costs		32			242			—			—		—			274
Other		396			—			25			185		—			606
	$	19,651		$	242		$	12,921		$	13,905	$	(18,837)		$	27,882
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	1		$	—		$	1,126		$	564	$	—		$	1,691
Accrued salaries		—			—			569			400		—			969
Other accrued expenses		247			454			400			792		—			1,893
Long-term debt due within one year		—			1,363			40			35		—			1,438
		248			1,817			2,135			1,791		—			5,991
Long-term debt		2,525			23,988			173			484		—			27,170
Intercompany balances		25,750			(11,633	)		(17,525	)		3,408		—			—
Professional liability risks		—			—			—			970		—			970
Income taxes and other liabilities		451			425			652			235		—			1,763
		28,974			14,597			(14,565	)		6,888		—			35,894
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,323	)		(14,355	)		27,394			5,798		(18,837	)		(9,323	)
Noncontrolling interests		—			—			92			1,219		—			1,311
		(9,323	)		(14,355	)		27,486			7,017		(18,837)			(8,012	)
	$	19,651		$	242		$	12,921		$	13,905	$	(18,837)		$	27,882

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	22		$	—		$	383		$	300	$	—		$	705
Accounts receivable, net		—			—			2,448			2,224		—			4,672
Inventories		—			—			629			457		—			1,086
Deferred income taxes		385			—			—			—		—			385
Other		122			—			342			451		—			915
		529			—			3,802			3,432		—			7,763
Property and equipment, net		—			—			7,417			5,768		—			13,185
Investments of insurance subsidiaries		—			—			—			515		—			515
Investments in and advances to affiliates		18,481			—			16			88		(18,481	)		104
Goodwill and other intangible assets		—			—			1,697			3,842		—			5,539
Deferred loan costs		32			258			—			—		—			290
Other		469			—			31			179		—			679
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,203		$	565	$	—		$	1,768
Accrued salaries		—			—			638			482		—			1,120
Other accrued expenses		30			567			464			788		—			1,849
Long-term debt due within one year		—			1,360			39			36		—			1,435
		30			1,927			2,344			1,871		—			6,172
Long-term debt		2,525			24,304			173			493		—			27,495
Intercompany balances		26,131			(12,407	)		(17,130	)		3,406		—			—
Professional liability risks		—			—			—			973		—			973
Income taxes and other liabilities		485			442			629			220		—			1,776
		29,171			14,266			(13,984	)		6,963		—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,660	)		(14,008	)		26,847			5,642		(18,481	)		(9,660	)
Noncontrolling interests		—			—			100			1,219		—			1,319
		(9,660	)		(14,008	)		26,947			6,861		(18,481	)		(8,341	)
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075

Schedule of Condensed Consolidating Statement of Cash Flows

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE QUARTER ENDED MARCH 31, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	326		$	(363	)	$	556		$	275		$	(356	)	$	438
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		49			(113	)		(671	)		(559	)		—			(1,294	)
Provision for doubtful accounts		—			—			443			311			—			754
Depreciation and amortization		—			—			209			215			—			424
Income taxes		350			—			—			—			—			350
Losses on sales of facilities		—			—			16			—			—			16
Loss on retirement of debt		—			17			—			—			—			17
Amortization of deferred loan costs		1			12			—			—			—			13
Share-based compensation		23			—			—			—			—			23
Equity in earnings of affiliates		(356	)		—			—			—			356			—
Other		—			2			1			(4	)		—			(1	)
Net cash provided by (used in) operating activities		393			(445	)		554			238			—			740
Cash flows from investing activities:
Purchase of property and equipment		—			—			(241	)		(163	)		—			(404	)
Acquisition of hospitals and health care entities		—			—			—			(22	)		—			(22	)
Disposition of hospitals and health care entities		—			—			1			—			—			1
Change in investments		—			—			5			46			—			51
Other		—			—			—			1			—			1
Net cash used in investing activities		—			—			(235	)		(138	)		—			(373	)
Cash flows from financing activities:
Net change in revolving bank credit facilities		—			390			—			—			—			390
Repayment of long-term debt		—			(718	)		(11	)		(12	)		—			(741	)
Distributions to noncontrolling interests		—			—			(21	)		(81	)		—			(102	)
Distributions to stockholders		(10	)		—			—			—			—			(10	)
Changes in intercompany balances with affiliates, net		(393	)		773			(398	)		18			—			—
Income tax benefits		36			—			—			—			—			36
Other		(47	)		—			—			(4	)		—			(51	)
Net cash (used in) provided by financing activities		(414	)		445			(430	)		(79	)		—			(478	)
Change in cash and cash equivalents		(21	)		—			(111	)		21			—			(111	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	1		$	—		$	272		$	321		$	—		$	594

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE QUARTERS ENDED MARCH 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	540		$	(333	)	$	677		$	315		$	(560	)	$	639
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		30			(116	)		(819	)		(479	)		—			(1,384	)
Provision for doubtful accounts		—			—			463			331			—			794
Depreciation and amortization		—			—			200			217			—			417
Income taxes		300			—			—			—			—			300
Losses on sales of facilities		—			—			1			—			—			1
Amortization of deferred loan costs		—			14			—			—			—			14
Share-based compensation		9			—			—			—			—			9
Equity in earnings of affiliates		(560	)		—			—			—			560			—
Other		—			4			—			3			—			7
Net cash provided by (used in) operating activities		319			(431	)		522			387			—			797
Cash flows from investing activities:
Purchase of property and equipment		—			—			(162	)		(173	)		—			(335	)
Acquisition of hospitals and health care entities		—			—			(62	)		(50	)		—			(112	)
Disposition of hospitals and health care entities		—			—			1			—			—			1
Change in investments		—			—			2			4			—			6
Other		—			—			—			3			—			3
Net cash used in investing activities		—			—			(221	)		(216	)		—			(437	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350			—			—			—			1,350
Net change in revolving bank credit facilities		—			(470	)		—			—			—			(470	)
Repayment of long-term debt		—			(76	)		(14	)		(3	)		—			(93	)
Distributions to noncontrolling interests		—			—			(18	)		(75	)		—			(93	)
Payment of debt issuance costs		—			(16	)		—			—			—			(16	)
Distributions to stockholders		(982	)		—			—			—			—			(982	)
Changes in intercompany balances with affiliates, net		624			(357	)		(240	)		(27	)		—			—
Income tax benefits		49			—			—			—			—			49
Other		(10	)		—			—			3			—			(7	)
Net cash (used in) provided by financing activities		(319	)		431			(272	)		(102	)		—			(262	)
Change in cash and cash equivalents		—			—			29			69			—			98
Cash and cash equivalents at beginning of period		—			—			115			258			—			373
Cash and cash equivalents at end of period	$	—		$	—		$	144		$	327		$	—		$	471

XML

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION - Schedule of Condensed Consolidating Statement of Cash Flows (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net income (loss)	$ 438	$ 639
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(1,294)	(1,384)
Provision for doubtful accounts	754	794
Depreciation and amortization	424	417
Income taxes	350	300
Losses (gains) on sales of facilities	16	1
Loss on retirement of debt	17
Amortization of deferred loan costs	13	14
Share-based compensation	23	9
Equity in earnings of affiliates	(8)	(11)
Other	(1)	7
Net cash provided by operating activities	740	797
Cash flows from investing activities:
Purchase of property and equipment	(404)	(335)
Acquisition of hospitals and health care entities	(22)	(112)
Disposition of hospitals and health care entities	1	1
Change in investments	51	6
Other	1	3
Net cash used in investing activities	(373)	(437)
Cash flows from financing activities:
Issuance of long-term debt		1,350
Net change in revolving bank credit facilities	390	(470)
Repayment of long-term debt	(741)	(93)
Distributions to non controlling interests	(102)	(93)
Payment of debt issuance costs		(16)
Distributions to stockholders	(10)	(982)
Income tax benefits	36	49
Other	(51)	(7)
Net cash used in financing activities	(478)	(262)
Change in cash and cash equivalents	(111)	98
Cash and cash equivalents at beginning of period	705	373
Cash and cash equivalents at end of period	594	471
HCA Holdings, Inc. Issuer [Member]
Cash flows from operating activities:
Net income (loss)	326	540
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	49	30
Provision for doubtful accounts
Depreciation and amortization
Income taxes	350	300
Losses (gains) on sales of facilities
Loss on retirement of debt
Amortization of deferred loan costs	1
Share-based compensation	23	9
Equity in earnings of affiliates	(356)	(560)
Net cash provided by operating activities	393	319
Cash flows from financing activities:
Distributions to stockholders	(10)	(982)
Changes in inter company balances with affiliates, net	(393)	624
Income tax benefits	36	49
Other	(47)	(10)
Net cash used in financing activities	(414)	(319)
Change in cash and cash equivalents	(21)
Cash and cash equivalents at beginning of period	22
Cash and cash equivalents at end of period	1
HCA Inc. Issuer [Member]
Cash flows from operating activities:
Net income (loss)	(363)	(333)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(113)	(116)
Provision for doubtful accounts
Depreciation and amortization
Losses (gains) on sales of facilities
Loss on retirement of debt	17
Amortization of deferred loan costs	12	14
Equity in earnings of affiliates
Other	2	4
Net cash provided by operating activities	(445)	(431)
Cash flows from financing activities:
Issuance of long-term debt		1,350
Net change in revolving bank credit facilities	390	(470)
Repayment of long-term debt	(718)	(76)
Payment of debt issuance costs		(16)
Changes in inter company balances with affiliates, net	773	(357)
Net cash used in financing activities	445	431
Cash and cash equivalents at end of period	0
Subsidiary Guarantors [Member]
Cash flows from operating activities:
Net income (loss)	556	677
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(671)	(819)
Provision for doubtful accounts	443	463
Depreciation and amortization	209	200
Losses (gains) on sales of facilities	16	1
Loss on retirement of debt
Equity in earnings of affiliates	(1)	(2)
Other	1
Net cash provided by operating activities	554	522
Cash flows from investing activities:
Purchase of property and equipment	(241)	(162)
Acquisition of hospitals and health care entities		(62)
Disposition of hospitals and health care entities	1	1
Change in investments	5	2
Net cash used in investing activities	(235)	(221)
Cash flows from financing activities:
Repayment of long-term debt	(11)	(14)
Distributions to non controlling interests	(21)	(18)
Changes in inter company balances with affiliates, net	(398)	(240)
Net cash used in financing activities	(430)	(272)
Change in cash and cash equivalents	(111)	29
Cash and cash equivalents at beginning of period	383	115
Cash and cash equivalents at end of period	272	144
Subsidiary Non-Guarantors [Member]
Cash flows from operating activities:
Net income (loss)	275	315
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(559)	(479)
Provision for doubtful accounts	311	331
Depreciation and amortization	215	217
Losses (gains) on sales of facilities
Loss on retirement of debt
Equity in earnings of affiliates	(7)	(9)
Other	(4)	3
Net cash provided by operating activities	238	387
Cash flows from investing activities:
Purchase of property and equipment	(163)	(173)
Acquisition of hospitals and health care entities	(22)	(50)
Change in investments	46	4
Other	1	3
Net cash used in investing activities	(138)	(216)
Cash flows from financing activities:
Repayment of long-term debt	(12)	(3)
Distributions to non controlling interests	(81)	(75)
Changes in inter company balances with affiliates, net	18	(27)
Other		3
Net cash used in financing activities	(79)	(102)
Change in cash and cash equivalents	21	69
Cash and cash equivalents at beginning of period	300	258
Cash and cash equivalents at end of period	321	327
Eliminations [Member]
Cash flows from operating activities:
Net income (loss)	(356)	(560)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for doubtful accounts
Depreciation and amortization
Losses (gains) on sales of facilities
Loss on retirement of debt
Equity in earnings of affiliates	356	560
Cash flows from financing activities:
Cash and cash equivalents at end of period	$ 0

XML

LONG-TERM DEBT - Schedule of Long-Term Debt (Detail) (USD $) In Millions, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
First lien debt	$ 17,914	$ 17,539
Total debt	28,608	28,930
Less amounts due within one year	1,438	1,435
Long-term debt	27,170	27,495
Senior secured asset-based revolving credit facility [Member]
Debt Instrument [Line Items]
Long-term line of credit	1,860	1,470
Senior secured revolving credit facility [Member]
Debt Instrument [Line Items]
Long-term line of credit	0
Senior secured term loan facilities [Member]
Debt Instrument [Line Items]
Term loans	5,941	5,958
Senior secured first lien notes [Member]
Debt Instrument [Line Items]
Senior secured first lien notes	9,689	9,688
Other senior secured debt [Member]
Debt Instrument [Line Items]
Other senior secured debt	424	423
Senior secured second lien notes [Member]
Debt Instrument [Line Items]
Senior secured second lien notes	0	197
Senior unsecured notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes	$ 10,694	$ 11,194

XML

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Schedule of Revenues from Third Party Payers and Uninsured (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenues [Line Items]
Revenues from third party payers	$ 8,490	$ 8,540
Uninsured	399	442
Other	305	217
Revenues before provision for doubtful accounts	9,194	9,199
Provision for doubtful accounts	(754)	(794)
Revenues	8,440	8,405
Revenues from third party payers, ratio	100.60%	101.60%
Uninsured Ratio	4.70%	5.30%
Other Ratio	3.60%	2.60%
Revenues before provision for doubtful accounts, ratio	108.90%	109.50%
Provision for doubtful accounts Ratio	(8.90%)	(9.50%)
Revenues ratio from third party payers	100.00%	100.00%
Medicare [Member]
Revenues [Line Items]
Revenues from third party payers	2,138	2,313
Revenues from third party payers, ratio	25.30%	27.50%
Managed Medicare [Member]
Revenues [Line Items]
Revenues from third party payers	843	750
Revenues from third party payers, ratio	10.00%	8.90%
Medicaid [Member]
Revenues [Line Items]
Revenues from third party payers	332	430
Revenues from third party payers, ratio	3.90%	5.10%
Managed Medicaid [Member]
Revenues [Line Items]
Revenues from third party payers	401	342
Revenues from third party payers, ratio	4.80%	4.10%
Managed care and other insurers [Member]
Revenues [Line Items]
Revenues from third party payers	4,486	4,445
Revenues from third party payers, ratio	53.20%	52.90%
International (managed care and other insurers) [Member]
Revenues [Line Items]
Revenues from third party payers	$ 290	$ 260
Revenues from third party payers, ratio	3.40%	3.10%

XML

ACQUISITIONS AND DISPOSITIONS - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended			3 Months Ended		3 Months Ended
	Mar. 31, 2012 HealthONE [Member]	Mar. 31, 2013 Other Healthcare Entity [Member]	Mar. 31, 2012 Other Healthcare Entity [Member]	Mar. 31, 2013 Hospitals [Member]	Mar. 31, 2012 Hospitals [Member]	Mar. 31, 2012 Real Estate [Member]
Business Acquisition [Line Items]
Cash paid for acquisition		$ 22	$ 54		$ 58
Liability assumed on acquisition					34
Goodwill recorded on acquisition					66
Increase in noncontrolling interests on business acquisition	30
Decrease in property and equipment on business acquisition	26
Increase in goodwill on business acquisition	56
Pretax loss on sales of business				$ 16		$ 1

XML

ACQUISITIONS AND DISPOSITIONS

3 Months Ended

Mar. 31, 2013

ACQUISITIONS AND DISPOSITIONS

NOTE 2 — ACQUISITIONS AND DISPOSITIONS

During the quarters ended March 31, 2013 and 2012, we paid $22 million and $54 million, respectively, to acquire nonhospital health care entities. During the quarter ended March 31, 2012, we paid $58 million, assumed liabilities of $34 million and recorded goodwill of $66 million related to the acquisition of a hospital facility in the American Group. During the quarter ended March 31, 2012, we recorded final adjustments to the purchase price allocation related to our 2011 acquisition of our partner’s interest in the HCA-HealthONE LLC joint venture. These adjustments resulted in a $30 million increase to noncontrolling interests, a $26 million reduction to property and equipment and a $56 million increase to goodwill.

During the quarter ended March 31, 2013, we recognized net pretax losses of $16 million related to the sale of a hospital facility and other real estate investments. During the quarter ended March 31, 2012, we recognized a net pretax loss of $1 million related to sales of real estate investments.

XML

INCOME TAXES - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Dec. 31, 2012
Income Tax Contingency [Line Items]
Liability for unrecognized tax benefits	$ 416		$ 426
Unrecognized tax benefits, accrued interest	14		14
Unrecognized tax benefits that would impact effective tax rate	127		125
Reductions In Interest Related To Taxing Authority Examinations	18	3
Reductions In Interest Related To Taxing Authority Examinations Net of Tax	$ 11	$ 2

XML

FINANCIAL INSTRUMENTS - Effect of Interest Rate and Cross Currency Swaps on Results of Operations (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013
Interest rate swaps [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Recognized in OCI on Derivatives, Net of Tax	$ 4
Interest rate swaps [Member] | Interest expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Reclassified from Accumulated OCI into Operations	32
Cross currency swap [Member] | Other operating expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Recognized in Operations on Derivatives	$ 9

XML

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION - Additional Information (Detail) (Senior unsecured notes due 2021 [Member], USD $) In Millions, unless otherwise specified	Dec. 06, 2012	Nov. 23, 2010
Senior unsecured notes due 2021 [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Debt instrument, principal amount	$ 1,000	$ 1,525
Debt instrument, stated interest	6.25%	7.75%

XML

CONDENSED CONSOLIDATED INCOME STATEMENTS (USD $) In Millions, except Share data in Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenues before provision for doubtful accounts	$ 9,194	$ 9,199
Provision for doubtful accounts	754	794
Revenues	8,440	8,405
Salaries and benefits	3,917	3,736
Supplies	1,479	1,419
Other operating expenses	1,523	1,493
Electronic health record incentive income	(39)	(55)
Equity in earnings of affiliates	(8)	(11)
Depreciation and amortization	424	417
Interest expense	472	442
Losses on sales of facilities	16	1
Loss on retirement of debt	17
Total expenses including equity in earnings of a affiliates	7,801	7,442
Income before income taxes	639	963
Provision for income taxes	201	324
Net income	438	639
Net income attributable to noncontrolling interests	94	99
Net income attributable to HCA Holdings, Inc.	$ 344	$ 540
Per share data:
Basic earnings per share	$ 0.77	$ 1.23
Diluted earnings per share	$ 0.74	$ 1.18
Cash dividends declared per share		$ 2.00
Shares used in earnings per share calculations (in thousands):
Basic	444,401	437,936
Diluted	462,368	458,312

XML

LONG-TERM DEBT - Schedule of Long-Term Debt (Parenthetical) (Detail)	Mar. 31, 2013
Debt Instrument [Line Items]
Total debt average term	6 years 10 months 24 days
Total debt average rate	6.50%
Senior secured asset-based revolving credit facility [Member]
Debt Instrument [Line Items]
Effective interest rate	1.70%
Senior secured term loan facilities [Member]
Debt Instrument [Line Items]
Effective interest rate	5.60%
Senior secured first lien notes [Member]
Debt Instrument [Line Items]
Effective interest rate	7.10%
Other senior secured debt [Member]
Debt Instrument [Line Items]
Effective interest rate	7.00%
Senior unsecured notes [Member]
Debt Instrument [Line Items]
Effective interest rate	7.20%

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net income	$ 438	$ 639
Adjustments to reconcile net income to net cash provided by operating activities:
Changes in operating assets and liabilities	(1,294)	(1,384)
Provision for doubtful accounts	754	794
Depreciation and amortization	424	417
Income taxes	350	300
Losses on sales of facilities	16	1
Loss on retirement of debt	17
Amortization of deferred loan costs	13	14
Share-based compensation	23	9
Other	(1)	7
Net cash provided by operating activities	740	797
Cash flows from investing activities:
Purchase of property and equipment	(404)	(335)
Acquisition of hospitals and health care entities	(22)	(112)
Disposition of hospitals and health care entities	1	1
Change in investments	51	6
Other	1	3
Net cash used in investing activities	(373)	(437)
Cash flows from financing activities:
Issuance of long-term debt		1,350
Net change in revolving credit facilities	390	(470)
Repayment of long-term debt	(741)	(93)
Distributions to noncontrolling interests	(102)	(93)
Payment of debt issuance costs		(16)
Distributions to stockholders	(10)	(982)
Income tax benefits	36	49
Other	(51)	(7)
Net cash used in financing activities	(478)	(262)
Change in cash and cash equivalents	(111)	98
Cash and cash equivalents at beginning of period	705	373
Cash and cash equivalents at end of period	594	471
Interest payments	533	517
Income tax refunds, net	$ (185)	$ (25)

XML

INVESTMENTS OF INSURANCE SUBSIDIARIES - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investments subject to restrictions	$ 9	$ 9
Distribution receivable from insurance subsidiary	$ 59
Available for sale securities expected maturity of debt securities	4 years 6 months
Available for sale securities average scheduled maturity	8 years 4 months 24 days
Auction rate securities [Member]
Schedule of Trading Securities and Other Trading Assets [Line Items]
Available for sale securities expected maturity of debt securities	5 years 9 months 18 days
Available for sale securities average scheduled maturity	23 years 10 months 24 days
Asset-backed securities [Member]
Schedule of Trading Securities and Other Trading Assets [Line Items]
Available for sale securities expected maturity of debt securities	3 years 8 months 12 days
Available for sale securities average scheduled maturity	23 years 8 months 12 days

XML

INVESTMENTS OF INSURANCE SUBSIDIARIES (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of Investments

A summary of our insurance subsidiaries’ investments at March 31, 2013 and December 31, 2012 follows (dollars in millions):

	March 31, 2013
	Amortized Cost		Unrealized Amounts				Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	391	$	22	$	(1)	$	412
Auction rate securities		74		—		(4)		70
Asset-backed securities		12		—		—		12
Money market funds		51		—		—		51
		528		22		(5)		545
Equity securities		2		1		—		3
	$	530	$	23	$	(5)		548
Amounts classified as current assets								(125	)
Investment carrying value							$	423

	December 31, 2012
	Amortized Cost		Unrealized Amounts				Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	395	$	23	$	—	$	418
Auction rate securities		74		—		(6)		68
Asset-backed securities		14		—		—		14
Money market funds		67		—		—		67
		550		23		(6)		567
Equity securities		2		1		—		3
	$	552	$	24	$	(6)		570
Amounts classified as current assets								(55	)
Investment carrying value							$	515

Schedule of Maturities of Investments

Scheduled maturities of investments in debt securities at March 31, 2013 were as follows (dollars in millions):

	Amortized Cost		Fair Value
Due in one year or less	$	56	$	56
Due after one year through five years		180		188
Due after five years through ten years		113		120
Due after ten years		93		99
		442		463
Auction rate securities		74		70
Asset-backed securities		12		12
	$	528	$	545

XML

INVESTMENTS OF INSURANCE SUBSIDIARIES - Schedule of Maturities of Investments (Detail) (USD $) In Millions, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Schedule of Available-for-sale Securities [Line Items]
Due in one year or less, Amortized Cost	$ 56
Due after one year through five years, Amortized Cost	180
Due after five years through ten years, Amortized Cost	113
Due after ten years, Amortized Cost	93
Amortized Cost, Total	442
Amortized Cost	528
Due in one year or less, Fair Value	56
Fair Value	548	570
Due after one year through five years, Fair Value	188
Due after five years through ten years, Fair Value	120
Due after ten years, Fair Value	99
Fair Value, Total	463
Fair Value	545
Auction rate securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	74
Fair Value	70
Asset-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	12
Fair Value	$ 12

XML

ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of March 31, 2013 and December 31, 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	March 31, 2013
				Fair Value Measurements Using
	Fair Value			Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	412		$	—		$	412		$	—
Auction rate securities		70			—			—			70
Asset-backed securities		12			—			12			—
Money market funds		51			51			—			—
		545			51			424			70
Equity securities		3			2			—			1
Investments of insurance subsidiaries		548			53			424			71
Less amounts classified as current assets		(125	)		(51	)		(74	)		—
	$	423		$	2		$	350		$	71
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	22		$	—		$	22		$	—
Interest rate swaps (Income taxes and other liabilities)		403			—			403			—

	December 31, 2012
	Fair Value			Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	418		$	—		$	418	$	—
Auction rate securities		68			—			—		68
Asset-backed securities		14			—			14		—
Money market funds		67			67			—		—
		567			67			432		68
Equity securities		3			1			—		2
Investments of insurance subsidiaries		570			68			432		70
Less amounts classified as current assets		(55	)		(55	)		—		—
	$	515		$	13		$	432	$	70
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
Interest rate swaps (Income taxes and other liabilities)		429			—			429		—

Schedule Related to Auction Rate and Equity Securities Investments of Insurance Subsidiaries at Fair Value

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the quarter ended March 31, 2013 (dollars in millions):

Asset balances at December 31, 2012	$	70
Unrealized gains included in other comprehensive income		1
Asset balances at March 31, 2013	$	71

XML

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

3 Months Ended

Mar. 31, 2013

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Reporting Entity

On November 17, 2006, HCA Inc. was acquired by a private investor group, including affiliates of or funds sponsored by Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co., BAML Capital Partners and HCA founder, Dr. Thomas F. Frist Jr. (collectively, the “Investors”) and by members of management and certain other investors. The transaction was accounted for as a recapitalization in our financial statements, with no adjustments to the historical basis of our assets and liabilities.

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure (the “Corporate Reorganization”). HCA Holdings, Inc. became the new parent company, and HCA Inc. became HCA Holdings, Inc.’s wholly-owned direct subsidiary. As part of the Corporate Reorganization, HCA Inc.’s outstanding shares of common stock were automatically converted, on a share for share basis, into identical shares of HCA Holdings, Inc.’s common stock. As a result of the Corporate Reorganization, HCA Holdings, Inc. was deemed the successor registrant to HCA Inc. under the Securities Exchange Act of 1934.

During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock. Upon the completion of a secondary offering in February 2013, we no longer qualify as a “controlled company” under the applicable New York Stock Exchange (“NYSE”) listing standards and will be required to appoint a board of directors comprised of a majority of independent members within one year of such date. Our common stock is traded on the NYSE (symbol “HCA”).

HCA Holdings, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At March 31, 2013, these affiliates owned and operated 162 hospitals, 113 freestanding surgery centers and provided extensive outpatient and ancillary services. HCA Holdings, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Inc. and its affiliates prior to the Corporate Reorganization and to HCA Holdings, Inc. and its affiliates after the Corporate Reorganization. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $66 million and $53 million for the quarters ended March 31, 2013 and 2012, respectively. Operating results for the quarter ended March 31, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2012.

Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters ended March 31, 2013 and 2012 are summarized in the following table (dollars in millions):

	2013			Ratio			2012			Ratio
Medicare	$	2,138			25.3	%	$	2,313			27.5	%
Managed Medicare		843			10.0			750			8.9
Medicaid		332			3.9			430			5.1
Managed Medicaid		401			4.8			342			4.1
Managed care and other insurers		4,486			53.2			4,445			52.9
International (managed care and other insurers)		290			3.4			260			3.1
		8,490			100.6			8,540			101.6
Uninsured		399			4.7			442			5.3
Other		305			3.6			217			2.6
Revenues before provision for doubtful accounts		9,194			108.9			9,199			109.5
Provision for doubtful accounts		(754	)		(8.9	)		(794	)		(9.5	)
Revenues	$	8,440			100.0	%	$	8,405			100.0	%

The growth rate in revenues for the quarter ended March 31, 2013 compared to the quarter ended March 31, 2012 was reduced due to Medicare revenues for the quarter ended March 31, 2012 being impacted by two adjustments: the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million. The net effect of these Medicare adjustments was an increase to revenues of $188 million. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the quarter ended March 31, 2012.

Certain prior year amounts have been reclassified to conform to the current year presentation.

XML

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Net income	$ 438	$ 639
Other comprehensive income (loss) before taxes:
Foreign currency translation	(60)	29
Unrealized gains on available-for-sale securities	1	5
Defined benefit plans
Less: pension costs included in salaries and benefits	7	7
Total defined benefit plans	7	7
Change in fair value of derivative financial instruments	(7)	(25)
Less: interest costs included in interest expense	32	29
Total change in fair value of derivative financial instruments	25	4
Other comprehensive income (loss) before taxes	(27)	45
Income taxes (benefits) related to other comprehensive income items	(9)	16
Other comprehensive income (loss)	(18)	29
Comprehensive income	420	668
Comprehensive income attributable to noncontrolling interests	94	99
Comprehensive income attributable to HCA Holdings, Inc.	$ 326	$ 569

XML

SEGMENT AND GEOGRAPHIC INFORMATION

3 Months Ended

Mar. 31, 2013

SEGMENT AND GEOGRAPHIC INFORMATION

NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION

We operate in one line of business, which is operating hospitals and related health care entities. Effective January 1, 2013, we reorganized our operational groups into two geographically organized groups: the National and American Groups. The National Group includes 77 hospitals located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia, and the American Group includes 79 hospitals located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. We also operate six hospitals in England, and these facilities are included in the Corporate and other group.

Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, losses on sales of facilities, loss on retirement of debt, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters ended March 31, 2013 and 2012 are summarized in the following table (dollars in millions):

	2013			2012
Revenues:
National Group	$	3,981		$	3,992
American Group		4,034			4,085
Corporate and other		425			328
	$	8,440		$	8,405
Equity in earnings of affiliates:
National Group	$	(2	)	$	(4	)
American Group		(6	)		(7	)
Corporate and other		—			—
	$	(8	)	$	(11	)
Adjusted segment EBITDA:
National Group	$	804		$	921
American Group		828			973
Corporate and other		(64	)		(71	)
	$	1,568		$	1,823
Depreciation and amortization:
National Group	$	174		$	173
American Group		202			203
Corporate and other		48			41
	$	424		$	417
Adjusted segment EBITDA	$	1,568		$	1,823
Depreciation and amortization		424			417
Interest expense		472			442
Losses on sales of facilities		16			1
Loss on retirement of debt		17			—
Income before income taxes	$	639		$	963

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2013	Apr. 30, 2013
Entity Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q1
Trading Symbol	HCA
Entity Registrant Name	HCA HOLDINGS, INC.
Entity Central Index Key	0000860730
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		446,077,900

XML

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

3 Months Ended

Mar. 31, 2013

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure. HCA Holdings, Inc. became the parent company, and HCA Inc. became HCA Holdings, Inc.’s wholly-owned direct subsidiary. On November 23, 2010, HCA Holdings, Inc. issued $1.525 billion aggregate principal amount of 7 ³/₄% senior unsecured notes due 2021. On December 6, 2012, HCA Holdings, Inc. issued $1.000 billion aggregate principal amount of 6.25% senior unsecured notes due 2021. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries.

The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, wholly-owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our senior secured asset-based revolving credit facility).

Our summarized condensed consolidating comprehensive income statements for the quarters ended March 31, 2013 and 2012, condensed consolidating balance sheets at March 31, 2013 and December 31, 2012 and condensed consolidating statements of cash flows for the quarter ended March 31, 2013 and 2012, segregating HCA Holdings, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow:

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED MARCH 31, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,872		$	4,322		$	—		$	9,194
Provision for doubtful accounts		—			—			443			311			—			754
Revenues		—			—			4,429			4,011			—			8,440
Salaries and benefits		—			—			2,127			1,790			—			3,917
Supplies		—			—			791			688			—			1,479
Other operating expenses		1			—			732			790			—			1,523
Electronic health record incentive income		—			—			(29	)		(10	)		—			(39	)
Equity in earnings of affiliates		(356	)		—			(1	)		(7	)		356			(8	)
Depreciation and amortization		—			—			209			215			—			424
Interest expense		46			558			(106	)		(26	)		—			472
Losses on sales of facilities		—			—			16			—			—			16
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(183	)		183			—			—
		(309	)		575			3,556			3,623			356			7,801
Income (loss) before income taxes		309			(575	)		873			388			(356	)		639
Provision (benefit) for income taxes		(17	)		(212	)		317			113			—			201
Net income (loss)		326			(363	)		556			275			(356	)		438
Net income attributable to noncontrolling interests		—			—			13			81			—			94
Net income (loss) attributable to HCA Holdings, Inc.	$	326		$	(363	)	$	543		$	194		$	(356	)	$	344
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	326		$	(347	)	$	547		$	156		$	(356	)	$	326

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED MARCH 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,903		$	4,296		$	—		$	9,199
Provision for doubtful accounts		—			—			463			331			—			794
Revenues		—			—			4,440			3,965			—			8,405
Salaries and benefits		—			—			1,982			1,754			—			3,736
Supplies		—			—			753			666			—			1,419
Other operating expenses		—			4			729			760			—			1,493
Electronic health record incentive income		—			—			(41	)		(14	)		—			(55	)
Equity in earnings of affiliates		(560	)		—			(2	)		(9	)		560			(11	)
Depreciation and amortization		—			—			200			217			—			417
Interest expense		30			529			(91	)		(26	)		—			442
Losses on sales of facilities		—			—			1			—			—			1
Management fees		—			—			(160	)		160			—			—
		(530	)		533			3,371			3,508			560			7,442
Income (loss) before income taxes		530			(533	)		1,069			457			(560	)		963
Provision (benefit) for income taxes		(10	)		(200	)		392			142			—			324
Net income (loss)		540			(333	)		677			315			(560	)		639
Net income attributable to noncontrolling interests		—			—			17			82			—			99
Net income (loss) attributable to HCA Holdings, Inc.	$	540		$	(333	)	$	660		$	233		$	(560	)	$	540
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	540		$	(329	)	$	664		$	254		$	(560	)	$	569

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

MARCH 31, 2013

(Dollars in millions)

	HCA Holdings,  Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	1		$	—		$	272		$	321	$	—		$	594
Accounts receivable, net		—			—			2,503			2,374		—			4,877
Inventories		—			—			647			457		—			1,104
Deferred income taxes		385			—			—			—		—			385
Other		—			—			317			510		—			827
		386			—			3,739			3,662		—			7,787
Property and equipment, net		—			—			7,444			5,700		—			13,144
Investments of insurance subsidiaries		—			—			—			423		—			423
Investments in and advances to affiliates		18,837			—			16			91		(18,837)			107
Goodwill and other intangible assets		—			—			1,697			3,844		—			5,541
Deferred loan costs		32			242			—			—		—			274
Other		396			—			25			185		—			606
	$	19,651		$	242		$	12,921		$	13,905	$	(18,837)		$	27,882
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	1		$	—		$	1,126		$	564	$	—		$	1,691
Accrued salaries		—			—			569			400		—			969
Other accrued expenses		247			454			400			792		—			1,893
Long-term debt due within one year		—			1,363			40			35		—			1,438
		248			1,817			2,135			1,791		—			5,991
Long-term debt		2,525			23,988			173			484		—			27,170
Intercompany balances		25,750			(11,633	)		(17,525	)		3,408		—			—
Professional liability risks		—			—			—			970		—			970
Income taxes and other liabilities		451			425			652			235		—			1,763
		28,974			14,597			(14,565	)		6,888		—			35,894
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,323	)		(14,355	)		27,394			5,798		(18,837	)		(9,323	)
Noncontrolling interests		—			—			92			1,219		—			1,311
		(9,323	)		(14,355	)		27,486			7,017		(18,837)			(8,012	)
	$	19,651		$	242		$	12,921		$	13,905	$	(18,837)		$	27,882

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	22		$	—		$	383		$	300	$	—		$	705
Accounts receivable, net		—			—			2,448			2,224		—			4,672
Inventories		—			—			629			457		—			1,086
Deferred income taxes		385			—			—			—		—			385
Other		122			—			342			451		—			915
		529			—			3,802			3,432		—			7,763
Property and equipment, net		—			—			7,417			5,768		—			13,185
Investments of insurance subsidiaries		—			—			—			515		—			515
Investments in and advances to affiliates		18,481			—			16			88		(18,481	)		104
Goodwill and other intangible assets		—			—			1,697			3,842		—			5,539
Deferred loan costs		32			258			—			—		—			290
Other		469			—			31			179		—			679
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,203		$	565	$	—		$	1,768
Accrued salaries		—			—			638			482		—			1,120
Other accrued expenses		30			567			464			788		—			1,849
Long-term debt due within one year		—			1,360			39			36		—			1,435
		30			1,927			2,344			1,871		—			6,172
Long-term debt		2,525			24,304			173			493		—			27,495
Intercompany balances		26,131			(12,407	)		(17,130	)		3,406		—			—
Professional liability risks		—			—			—			973		—			973
Income taxes and other liabilities		485			442			629			220		—			1,776
		29,171			14,266			(13,984	)		6,963		—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,660	)		(14,008	)		26,847			5,642		(18,481	)		(9,660	)
Noncontrolling interests		—			—			100			1,219		—			1,319
		(9,660	)		(14,008	)		26,947			6,861		(18,481	)		(8,341	)
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE QUARTER ENDED MARCH 31, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	326		$	(363	)	$	556		$	275		$	(356	)	$	438
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		49			(113	)		(671	)		(559	)		—			(1,294	)
Provision for doubtful accounts		—			—			443			311			—			754
Depreciation and amortization		—			—			209			215			—			424
Income taxes		350			—			—			—			—			350
Losses on sales of facilities		—			—			16			—			—			16
Loss on retirement of debt		—			17			—			—			—			17
Amortization of deferred loan costs		1			12			—			—			—			13
Share-based compensation		23			—			—			—			—			23
Equity in earnings of affiliates		(356	)		—			—			—			356			—
Other		—			2			1			(4	)		—			(1	)
Net cash provided by (used in) operating activities		393			(445	)		554			238			—			740
Cash flows from investing activities:
Purchase of property and equipment		—			—			(241	)		(163	)		—			(404	)
Acquisition of hospitals and health care entities		—			—			—			(22	)		—			(22	)
Disposition of hospitals and health care entities		—			—			1			—			—			1
Change in investments		—			—			5			46			—			51
Other		—			—			—			1			—			1
Net cash used in investing activities		—			—			(235	)		(138	)		—			(373	)
Cash flows from financing activities:
Net change in revolving bank credit facilities		—			390			—			—			—			390
Repayment of long-term debt		—			(718	)		(11	)		(12	)		—			(741	)
Distributions to noncontrolling interests		—			—			(21	)		(81	)		—			(102	)
Distributions to stockholders		(10	)		—			—			—			—			(10	)
Changes in intercompany balances with affiliates, net		(393	)		773			(398	)		18			—			—
Income tax benefits		36			—			—			—			—			36
Other		(47	)		—			—			(4	)		—			(51	)
Net cash (used in) provided by financing activities		(414	)		445			(430	)		(79	)		—			(478	)
Change in cash and cash equivalents		(21	)		—			(111	)		21			—			(111	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	1		$	—		$	272		$	321		$	—		$	594

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE QUARTERS ENDED MARCH 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	540		$	(333	)	$	677		$	315		$	(560	)	$	639
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		30			(116	)		(819	)		(479	)		—			(1,384	)
Provision for doubtful accounts		—			—			463			331			—			794
Depreciation and amortization		—			—			200			217			—			417
Income taxes		300			—			—			—			—			300
Losses on sales of facilities		—			—			1			—			—			1
Amortization of deferred loan costs		—			14			—			—			—			14
Share-based compensation		9			—			—			—			—			9
Equity in earnings of affiliates		(560	)		—			—			—			560			—
Other		—			4			—			3			—			7
Net cash provided by (used in) operating activities		319			(431	)		522			387			—			797
Cash flows from investing activities:
Purchase of property and equipment		—			—			(162	)		(173	)		—			(335	)
Acquisition of hospitals and health care entities		—			—			(62	)		(50	)		—			(112	)
Disposition of hospitals and health care entities		—			—			1			—			—			1
Change in investments		—			—			2			4			—			6
Other		—			—			—			3			—			3
Net cash used in investing activities		—			—			(221	)		(216	)		—			(437	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350			—			—			—			1,350
Net change in revolving bank credit facilities		—			(470	)		—			—			—			(470	)
Repayment of long-term debt		—			(76	)		(14	)		(3	)		—			(93	)
Distributions to noncontrolling interests		—			—			(18	)		(75	)		—			(93	)
Payment of debt issuance costs		—			(16	)		—			—			—			(16	)
Distributions to stockholders		(982	)		—			—			—			—			(982	)
Changes in intercompany balances with affiliates, net		624			(357	)		(240	)		(27	)		—			—
Income tax benefits		49			—			—			—			—			49
Other		(10	)		—			—			3			—			(7	)
Net cash (used in) provided by financing activities		(319	)		431			(272	)		(102	)		—			(262	)
Change in cash and cash equivalents		—			—			29			69			—			98
Cash and cash equivalents at beginning of period		—			—			115			258			—			373
Cash and cash equivalents at end of period	$	—		$	—		$	144		$	327		$	—		$	471

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Millions, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 594	$ 705
Accounts receivable, less allowance for doubtful accounts of $4,796 and $4,846	4,877	4,672
Inventories	1,104	1,086
Deferred income taxes	385	385
Other	827	915
Total current assets	7,787	7,763
Property and equipment, at cost	29,764	29,527
Accumulated depreciation	(16,620)	(16,342)
Property and equipment, net	13,144	13,185
Investments of insurance subsidiaries	423	515
Investments in and advances to affiliates	107	104
Goodwill and other intangible assets	5,541	5,539
Deferred loan costs	274	290
Other	606	679
Total assets	27,882	28,075
Current liabilities:
Accounts payable	1,691	1,768
Accrued salaries	969	1,120
Other accrued expenses	1,893	1,849
Long-term debt due within one year	1,438	1,435
Total current liabilities	5,991	6,172
Long-term debt	27,170	27,495
Professional liability risks	970	973
Income taxes and other liabilities	1,763	1,776
Stockholders' deficit:
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 445,856,200 shares in 2013 and 443,200,200 shares in 2012	4	4
Capital in excess of par value	1,764	1,753
Accumulated other comprehensive loss	(475)	(457)
Retained deficit	(10,616)	(10,960)
Stockholders' deficit attributable to HCA Holdings, Inc.	(9,323)	(9,660)
Noncontrolling interests	1,311	1,319
Total stockholders' deficit	(8,012)	(8,341)
Total liabilities and stockholders' deficit	$ 27,882	$ 28,075

XML

FINANCIAL INSTRUMENTS

3 Months Ended

Mar. 31, 2013

FINANCIAL INSTRUMENTS

NOTE 6 — FINANCIAL INSTRUMENTS

Interest Rate Swap Agreements

We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at March 31, 2013 (dollars in millions):

	Notional Amount		Maturity Date		Fair Value
Pay-fixed interest rate swaps	$	500		December 2014	$	(8	)
Pay-fixed interest rate swaps		3,000		December 2016		(326	)
Pay-fixed interest rate swaps		1,000		December 2017		(69	)

During the next 12 months, we estimate $125 million will be reclassified from other comprehensive income (“OCI”) to interest expense.

Cross Currency Swaps

The Company and certain subsidiaries have incurred obligations and entered into various intercompany transactions where such obligations are denominated in currencies, other than the functional currencies of the parties executing the trade. In order to mitigate the currency exposure risks and better match the cash flows of our obligations and intercompany transactions with cash flows from operations, we enter into cross currency swaps. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

Our cross currency swap is not designated as a hedge, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement at March 31, 2013 (amounts in millions):

	Notional Amount		Maturity Date		Fair Value
Euro — United States dollar currency swap		241 Euro		November 2013	$	(22	)

Derivatives — Results of Operations

The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the quarter ended March 31, 2013 (dollars in millions):

Derivatives in Cash Flow Hedging Relationships	Amount of Loss Recognized in OCI on Derivatives, Net of  Tax		Location of Loss Reclassified from Accumulated OCI into Operations		Amount of Loss Reclassified from Accumulated OCI into Operations
Interest rate swaps	$	4		Interest expense	$	32

Derivatives Not Designated as Hedging Instruments	Location of Loss Recognized in Operations on Derivatives		Amount of Loss Recognized in Operations on Derivatives
Cross currency swap		Other operating expenses	$	9

Credit-risk-related Contingent Features

We have agreements with each of our derivative counterparties that contain a provision where we could be declared in default on our derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to our default on the indebtedness. As of March 31, 2013, we have not been required to post any collateral related to these agreements. If we had breached these provisions at March 31, 2013, we would have been required to settle our obligations under the agreements at their aggregate, estimated termination value of $452 million.

XML

INVESTMENTS OF INSURANCE SUBSIDIARIES

3 Months Ended

Mar. 31, 2013

INVESTMENTS OF INSURANCE SUBSIDIARIES

NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES

A summary of our insurance subsidiaries’ investments at March 31, 2013 and December 31, 2012 follows (dollars in millions):

	March 31, 2013
	Amortized Cost		Unrealized Amounts				Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	391	$	22	$	(1)	$	412
Auction rate securities		74		—		(4)		70
Asset-backed securities		12		—		—		12
Money market funds		51		—		—		51
		528		22		(5)		545
Equity securities		2		1		—		3
	$	530	$	23	$	(5)		548
Amounts classified as current assets								(125	)
Investment carrying value							$	423

	December 31, 2012
	Amortized Cost		Unrealized Amounts				Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	395	$	23	$	—	$	418
Auction rate securities		74		—		(6)		68
Asset-backed securities		14		—		—		14
Money market funds		67		—		—		67
		550		23		(6)		567
Equity securities		2		1		—		3
	$	552	$	24	$	(6)		570
Amounts classified as current assets								(55	)
Investment carrying value							$	515

At March 31, 2013 and December 31, 2012, the investments of our insurance subsidiaries were classified as “available-for-sale.” Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income. At both March 31, 2013 and December 31, 2012, $9 million of our investments were subject to restrictions included in insurance bond collateralization and assumed reinsurance contracts. Amounts classified as current assets at March 31, 2013 include a $59 million distribution receivable by the Company from an insurance subsidiary.

Scheduled maturities of investments in debt securities at March 31, 2013 were as follows (dollars in millions):

	Amortized Cost		Fair Value
Due in one year or less	$	56	$	56
Due after one year through five years		180		188
Due after five years through ten years		113		120
Due after ten years		93		99
		442		463
Auction rate securities		74		70
Asset-backed securities		12		12
	$	528	$	545

The average expected maturity of the investments in debt securities at March 31, 2013 was 4.5 years, compared to the average scheduled maturity of 8.4 years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to the scheduled maturity date. The average expected maturities for our auction rate and asset-backed securities were derived from valuation models of expected cash flows and involved management’s judgment. At March 31, 2013, the average expected maturities for our auction rate and asset-backed securities were 5.8 years and 3.7 years, respectively, compared to average scheduled maturities of 23.9 years and 23.7 years, respectively.

XML

FINANCIAL INSTRUMENTS (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of Interest Rate Swap Agreements Designated as Cash Flow Hedges

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at March 31, 2013 (dollars in millions):

	Notional Amount		Maturity Date		Fair Value
Pay-fixed interest rate swaps	$	500		December 2014	$	(8	)
Pay-fixed interest rate swaps		3,000		December 2016		(326	)
Pay-fixed interest rate swaps		1,000		December 2017		(69	)

Schedule of Cross Currency Swap Agreement Not Designated as Hedge

Our cross currency swap is not designated as a hedge, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement at March 31, 2013 (amounts in millions):

	Notional Amount		Maturity Date		Fair Value
Euro — United States dollar currency swap		241 Euro		November 2013	$	(22	)

Effect of Interest Rate and Cross Currency Swaps on Results of Operations

The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the quarter ended March 31, 2013 (dollars in millions):

Derivatives in Cash Flow Hedging Relationships	Amount of Loss Recognized in OCI on Derivatives, Net of  Tax		Location of Loss Reclassified from Accumulated OCI into Operations		Amount of Loss Reclassified from Accumulated OCI into Operations
Interest rate swaps	$	4		Interest expense	$	32

Derivatives Not Designated as Hedging Instruments	Location of Loss Recognized in Operations on Derivatives		Amount of Loss Recognized in Operations on Derivatives
Cross currency swap		Other operating expenses	$	9

XML

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Policies)

3 Months Ended

Mar. 31, 2013

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $66 million and $53 million for the quarters ended March 31, 2013 and 2012, respectively. Operating results for the quarter ended March 31, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2012.

Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters ended March 31, 2013 and 2012 are summarized in the following table (dollars in millions):

	2013			Ratio			2012			Ratio
Medicare	$	2,138			25.3	%	$	2,313			27.5	%
Managed Medicare		843			10.0			750			8.9
Medicaid		332			3.9			430			5.1
Managed Medicaid		401			4.8			342			4.1
Managed care and other insurers		4,486			53.2			4,445			52.9
International (managed care and other insurers)		290			3.4			260			3.1
		8,490			100.6			8,540			101.6
Uninsured		399			4.7			442			5.3
Other		305			3.6			217			2.6
Revenues before provision for doubtful accounts		9,194			108.9			9,199			109.5
Provision for doubtful accounts		(754	)		(8.9	)		(794	)		(9.5	)
Revenues	$	8,440			100.0	%	$	8,405			100.0	%

The growth rate in revenues for the quarter ended March 31, 2013 compared to the quarter ended March 31, 2012 was reduced due to Medicare revenues for the quarter ended March 31, 2012 being impacted by two adjustments: the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million. The net effect of these Medicare adjustments was an increase to revenues of $188 million. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the quarter ended March 31, 2012.

Certain prior year amounts have been reclassified to conform to the current year presentation.

XML

CONTINGENCIES AND LEGAL CLAIM COSTS

3 Months Ended

Mar. 31, 2013

CONTINGENCIES AND LEGAL CLAIM COSTS

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations or financial position.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

As initially disclosed in 2010, the Civil Division of the Department of Justice (“DOJ”) has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other than peer reviews). The Company is cooperating with the government’s request and is currently producing medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.

Securities Class Action Litigation

On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court heard argument on the motion in April 2013. A decision on the motion is anticipated mid-to-late 2013.

In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions have been consolidated in the Middle District of Tennessee and the parties have agreed that those cases shall be stayed pending developments in the shareholder class actions. The state derivative action has also been stayed pending developments in the shareholder class actions.

Health Midwest Litigation

In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. Should the accounting fail to satisfy the Court concerning HCA’s compliance with its capital and charity care commitments, the amount of the judgment award could substantially increase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are about $12 million. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling; however, the Company plans to appeal the ruling.

XML

ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

3 Months Ended

Mar. 31, 2013

ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.

ASC 820 emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Cash Traded Investments

Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The transaction price is initially used as the best estimate of fair value.

Our wholly-owned insurance subsidiaries had investments in tax-exempt auction rate securities (“ARS”), which are backed by student loans substantially guaranteed by the federal government, of $70 million ($74 million par value) at March 31, 2013. We do not currently intend to attempt to sell the ARS as the liquidity needs of our insurance subsidiaries are expected to be met by other investments in their investment portfolios. During 2012, certain issuers and their broker/dealers redeemed or repurchased $65 million of our ARS at par value. There were no redemptions or repurchases during the quarter ended March 31, 2013. The valuation of these securities involved management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived a fair market value compared to tax-equivalent yields of other student loan backed variable rate securities of similar credit worthiness and similar effective maturities.

Derivative Financial Instruments

We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. We incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.

Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at March 31, 2013 and December 31, 2012, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of March 31, 2013 and December 31, 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	March 31, 2013
				Fair Value Measurements Using
	Fair Value			Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	412		$	—		$	412		$	—
Auction rate securities		70			—			—			70
Asset-backed securities		12			—			12			—
Money market funds		51			51			—			—
		545			51			424			70
Equity securities		3			2			—			1
Investments of insurance subsidiaries		548			53			424			71
Less amounts classified as current assets		(125	)		(51	)		(74	)		—
	$	423		$	2		$	350		$	71
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	22		$	—		$	22		$	—
Interest rate swaps (Income taxes and other liabilities)		403			—			403			—

Derivative Financial Instruments (continued)

	December 31, 2012
	Fair Value			Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	418		$	—		$	418	$	—
Auction rate securities		68			—			—		68
Asset-backed securities		14			—			14		—
Money market funds		67			67			—		—
		567			67			432		68
Equity securities		3			1			—		2
Investments of insurance subsidiaries		570			68			432		70
Less amounts classified as current assets		(55	)		(55	)		—		—
	$	515		$	13		$	432	$	70
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
Interest rate swaps (Income taxes and other liabilities)		429			—			429		—

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the quarter ended March 31, 2013 (dollars in millions):

Asset balances at December 31, 2012	$	70
Unrealized gains included in other comprehensive income		1
Asset balances at March 31, 2013	$	71

The estimated fair value of our long-term debt was $30.572 billion and $30.781 billion at March 31, 2013 and December 31, 2012, respectively, compared to carrying amounts aggregating $28.608 billion and $28.930 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

XML

LONG-TERM DEBT

3 Months Ended

Mar. 31, 2013

LONG-TERM DEBT

NOTE 8 — LONG-TERM DEBT

A summary of long-term debt at March 31, 2013 and December 31, 2012, including related interest rates at March 31, 2013, follows (dollars in millions):

	March 31, 2013		December 31, 2012
Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	1,860	$	1,470
Senior secured revolving credit facility		—		—
Senior secured term loan facilities (effective interest rate of 5.6%)		5,941		5,958
Senior secured first lien notes (effective interest rate of 7.1%)		9,689		9,688
Other senior secured debt (effective interest rate of 7.0%)		424		423
First lien debt		17,914		17,539
Senior secured second lien notes		—		197
Senior unsecured notes (effective interest rate of 7.2%)		10,694		11,194
Total debt (average life of 6.9 years, rates averaging 6.5%)		28,608		28,930
Less amounts due within one year		1,438		1,435
	$	27,170	$	27,495

2013 Activity

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 7/8% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

XML

CAPITAL STRUCTURE

3 Months Ended

Mar. 31, 2013

CAPITAL STRUCTURE

NOTE 10 — CAPITAL STRUCTURE

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):

	Equity (Deficit) Attributable to HCA Holdings, Inc.													Equity Attributable to Noncontrolling Interests			Total
	Common Stock				Capital in Excess  of Par Value			Accumulated Other Comprehensive Loss			Retained Deficit
	Shares (000)		ParValue
Balances at December 31, 2012		443,200	$	4	$	1,753		$	(457	)	$	(10,960	)	$	1,319		$	(8,341	)
Net income		—		—		—			—			344			94			438
Other comprehensive loss		—		—		—			(18	)		—			—			(18	)
Distributions		—		—		—			—			—			(102	)		(102	)
Share-based benefit plans		2,656		—		15			—			—			—			15
Other		—		—		(4	)		—			—			—			(4	)
Balances at March 31, 2013		445,856	$	4	$	1,764		$	(475	)	$	(10,616	)	$	1,311		$	(8,012	)

The components of accumulated other comprehensive loss are as follows (dollars in millions):

	Unrealized Gains on Available- for-Sale Securities		Foreign Currency Translation Adjustments			Defined Benefit Plans			Change in Fair Value of Derivative Instruments			Total
Balances at December 31, 2012	$	11	$	(1	)	$	(196	)	$	(271	)	$	(457	)
Unrealized gains on available-for-sale securities, net of income taxes		1		—			—			—			1
Foreign currency translation adjustments, net of $21 income tax benefit		—		(39	)		—			—			(39	)
Defined benefit plans		—		—			—			—			—
Change in fair value of derivative instruments, net of $3 income tax benefit		—		—			—			(4	)		(4	)
Expense reclassified into operations from other comprehensive income, net of $3 and $12, respectively, income tax benefits		—		—			4			20			24
Balances at March 31, 2013	$	12	$	(40	)	$	(192	)	$	(255	)	$	(475	)

XML

INVESTMENTS OF INSURANCE SUBSIDIARIES - Schedule of Investments (Detail) (USD $) In Millions, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Available For Sale Securities [Line Items]
Amortized Cost	$ 530	$ 552
Unrealized Amounts, Gains	23	24
Unrealized Amounts, Losses	(5)	(6)
Fair Value	548	570
Amounts classified as current assets	(125)	(55)
Investment carrying value	423	515
Auction rate securities [Member]
Available For Sale Securities [Line Items]
Fair Value	70
Debt securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	528	550
Unrealized Amounts, Gains	22	23
Unrealized Amounts, Losses	(5)	(6)
Fair Value	545	567
Debt securities [Member] | States and municipalities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	391	395
Unrealized Amounts, Gains	22	23
Unrealized Amounts, Losses	(1)
Fair Value	412	418
Debt securities [Member] | Auction rate securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	74	74
Unrealized Amounts, Losses	(4)	(6)
Fair Value	70	68
Debt securities [Member] | Asset-backed securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	12	14
Fair Value	12	14
Debt securities [Member] | Money market funds [Member]
Available For Sale Securities [Line Items]
Amortized Cost	51	67
Fair Value	51	67
Equity securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	2	2
Unrealized Amounts, Gains	1	1
Fair Value	$ 3	$ 3

XML

SEGMENT AND GEOGRAPHIC INFORMATION - Additional Information (Detail)	Mar. 31, 2013
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	162
Reorganization Group [Member]
Segment Reporting Information [Line Items]
Number of geographically organized groups	2
Reorganization Group [Member] | National Group [Member]
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	77
Reorganization Group [Member] | American Group [Member]
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	79
Reorganization Group [Member] | Corporate and Other [Member]
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	6

XML

EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of Computations of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share for the quarters ended March 31, 2013 and 2012 (dollars in millions, except per share amounts, and shares in thousands):

	2013		2012
Net income attributable to HCA Holdings, Inc.	$	344	$	540
Weighted average common shares outstanding		444,401		437,936
Effect of dilutive incremental shares		17,967		20,376
Shares used for diluted earnings per share		462,368		458,312
Earnings per share:
Basic earnings per share	$	0.77	$	1.23
Diluted earnings per share	$	0.74	$	1.18

XML

CAPITAL STRUCTURE (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of Changes in Stockholders' Deficit and Equity

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):

	Equity (Deficit) Attributable to HCA Holdings, Inc.													Equity Attributable to Noncontrolling Interests			Total
	Common Stock				Capital in Excess  of Par Value			Accumulated Other Comprehensive Loss			Retained Deficit
	Shares (000)		ParValue
Balances at December 31, 2012		443,200	$	4	$	1,753		$	(457	)	$	(10,960	)	$	1,319		$	(8,341	)
Net income		—		—		—			—			344			94			438
Other comprehensive loss		—		—		—			(18	)		—			—			(18	)
Distributions		—		—		—			—			—			(102	)		(102	)
Share-based benefit plans		2,656		—		15			—			—			—			15
Other		—		—		(4	)		—			—			—			(4	)
Balances at March 31, 2013		445,856	$	4	$	1,764		$	(475	)	$	(10,616	)	$	1,311		$	(8,012	)

Components of Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss are as follows (dollars in millions):

	Unrealized Gains on Available- for-Sale Securities		Foreign Currency Translation Adjustments			Defined Benefit Plans			Change in Fair Value of Derivative Instruments			Total
Balances at December 31, 2012	$	11	$	(1	)	$	(196	)	$	(271	)	$	(457	)
Unrealized gains on available-for-sale securities, net of income taxes		1		—			—			—			1
Foreign currency translation adjustments, net of $21 income tax benefit		—		(39	)		—			—			(39	)
Defined benefit plans		—		—			—			—			—
Change in fair value of derivative instruments, net of $3 income tax benefit		—		—			—			(4	)		(4	)
Expense reclassified into operations from other comprehensive income, net of $3 and $12, respectively, income tax benefits		—		—			4			20			24
Balances at March 31, 2013	$	12	$	(40	)	$	(192	)	$	(255	)	$	(475	)

XML

CAPITAL STRUCTURE - Components of Accumulated Other Comprehensive Loss (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013
Accumulated Other Comprehensive Income Loss [Line Items]
Unrealized gains on available-for-sale securities, beginning balance	$ 11
Unrealized gains on available-for-sale securities	1
Unrealized gains on available-for-sale securities, ending balance	12
Foreign currency translation adjustments, beginning balance	(1)
Foreign currency translation adjustments	(39)
Foreign currency translation adjustments, ending balance	(40)
Defined benefit plans, beginning balance	(196)
Defined benefit plans, expense reclassified into operations from other comprehensive income	4
Defined benefit plans, ending balance	(192)
Change in fair value of derivative instruments, beginning balance	(271)
Change in fair value of derivative instruments	(4)
Change in fair value of derivative instruments, expense reclassified into operations from other comprehensive income	20
Change in fair value of derivative instruments, ending balance	(255)
Accumulated other comprehensive income, net of tax, beginning balance	(457)
Unrealized gains on available-for-sale securities, net of income taxes	1
Foreign currency translation adjustments, net of income tax benefit	(39)
Change in fair value of derivative instruments, net of income tax benefit	(4)
Expense reclassified into operations from other comprehensive income, Total	24
Accumulated other comprehensive income, net of tax, Ending balance	$ (475)

XML

ASSETS AND LIABILITIES MEASURED AT FAIR VALUE - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended	12 Months Ended
	Mar. 31, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Insurance subsidiaries investments, Fair Value	$ 548	$ 570
Investments in tax-exempt ARS at par value	528
Estimated fair value of long-term debt	30,572	30,781
Carrying amounts of long-term debt	28,608	28,930
Auction rate securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Insurance subsidiaries investments, Fair Value	70
Investments in tax-exempt ARS at par value	74
Redeemed or repurchased of ARS at par value	$ 0	$ 65

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) In Millions, except Share data, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Allowance for Accounts receivable	$ 4,796	$ 4,846
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	1,800,000,000	1,800,000,000
Common stock, shares outstanding	445,856,200	443,200,200

XML

EARNINGS PER SHARE

3 Months Ended

Mar. 31, 2013

EARNINGS PER SHARE

NOTE 4 — EARNINGS PER SHARE

We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding, plus the dilutive effect of outstanding stock options, stock appreciation rights and restricted share units, computed using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share for the quarters ended March 31, 2013 and 2012 (dollars in millions, except per share amounts, and shares in thousands):

	2013		2012
Net income attributable to HCA Holdings, Inc.	$	344	$	540
Weighted average common shares outstanding		444,401		437,936
Effect of dilutive incremental shares		17,967		20,376
Shares used for diluted earnings per share		462,368		458,312
Earnings per share:
Basic earnings per share	$	0.77	$	1.23
Diluted earnings per share	$	0.74	$	1.18

XML

SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of Geographic Distributions of Revenues, Equity in Earnings of Affiliates, Adjusted Segment Ebitda, Depreciation and Amortization and Assets

The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters ended March 31, 2013 and 2012 are summarized in the following table (dollars in millions):

	2013			2012
Revenues:
National Group	$	3,981		$	3,992
American Group		4,034			4,085
Corporate and other		425			328
	$	8,440		$	8,405
Equity in earnings of affiliates:
National Group	$	(2	)	$	(4	)
American Group		(6	)		(7	)
Corporate and other		—			—
	$	(8	)	$	(11	)
Adjusted segment EBITDA:
National Group	$	804		$	921
American Group		828			973
Corporate and other		(64	)		(71	)
	$	1,568		$	1,823
Depreciation and amortization:
National Group	$	174		$	173
American Group		202			203
Corporate and other		48			41
	$	424		$	417
Adjusted segment EBITDA	$	1,568		$	1,823
Depreciation and amortization		424			417
Interest expense		472			442
Losses on sales of facilities		16			1
Loss on retirement of debt		17			—
Income before income taxes	$	639		$	963

XML

FINANCIAL INSTRUMENTS - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013
Derivative Instruments And Hedging Activities [Line Items]
Estimated amount reclassified from other comprehensive income to interest expense	$ 125
Estimated termination value if there is breach of provision related to derivative agreement	$ 452

XML

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Tables)

3 Months Ended

Mar. 31, 2013

Schedule of Revenues from Third Party Payers and Uninsured

Our revenues from third-party payers and the uninsured for the quarters ended March 31, 2013 and 2012 are summarized in the following table (dollars in millions):

	2013			Ratio			2012			Ratio
Medicare	$	2,138			25.3	%	$	2,313			27.5	%
Managed Medicare		843			10.0			750			8.9
Medicaid		332			3.9			430			5.1
Managed Medicaid		401			4.8			342			4.1
Managed care and other insurers		4,486			53.2			4,445			52.9
International (managed care and other insurers)		290			3.4			260			3.1
		8,490			100.6			8,540			101.6
Uninsured		399			4.7			442			5.3
Other		305			3.6			217			2.6
Revenues before provision for doubtful accounts		9,194			108.9			9,199			109.5
Provision for doubtful accounts		(754	)		(8.9	)		(794	)		(9.5	)
Revenues	$	8,440			100.0	%	$	8,405			100.0	%